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Abstract 
Kampa, Jaruwan. 2006. Epidemiology of Bovine Viral Diarrhoea Virus and Bovine 
Herpesvirus type 1 Infections in Dairy Cattle Herds: Evidence of self-clearance and 
detection of infection with a new atypical pestivirus. Doctoral thesis 
 
ISSN 1652-6880, ISBN 91-576-7126-5 
 
Bovine viral diarrhoea virus (BVDV) and bovine herpesvirus type 1 (BHV-1) infections are 
endemic and cause disease in cattle populations worldwide. The losses due to the diseases 
are high in affected countries and must be regarded as a serious animal welfare problem. In 
Sweden BHV-1 has been eradicated and more than 98% of the herds are BVDV free. This 
long-term study was conducted to obtain knowledge of relevance for control of both these 
infections in dairy herds in Thailand. The epidemiological pattern of BVDV and BHV-1 
infections was studied in 186 dairy herds by repeated bulk tank milk (BTM) analysis. A 
subset of 11 herds was selected for individual testing. The serum and BTM were tested for 
antibodies to the viruses using indirect ELISA tests. The results demonstrated a self-
clearance process of both infections at the herd/regional level, without any control 
measures. There was an apparently lack of reactivation of BHV-1 infected animals. A 
significant association of BHV-1 and BVDV indicate that common risk factors are 
associated with seropositivity. Factors discussed were the serological status of imported 
cows and artificial insemination activities. 
 
A low incidence rate of BVDV was found among breeding cattle in 5 out of 11 herds. 
One herd, however, had a high seroconversion rate to BVDV and a viraemic calf was 
identified by an E
rns capture ELISA. Genetic characterization showed that this calf was 
infected with a virus closely related to a recently described atypical pestivirus (HoBi) 
detected in a foetal calf serum from Brazil. Comparative neutralisation tests suggest that 
seroconversions in this herd were caused by the ‘HoBi-like’ virus and that it has been 
recently introduced to the region. Further studies must be performed to elucidate how this 
virus has been introduced to the cattle population in Thailand and it might have been spread 
to cattle all over the world. 
 
However, this study shows that the self clearance process in Thai dairy herds of both 
BVDV and BHV-1 infections will probably continue if there is awareness of biosecurity. 
Imported animals and biological products should be secured free from both BVDV and 
BHV-1.    
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Introduction 
Dairy production in Thailand 
The dairy industry in Thailand today was first established in the early 1960s in the 
central region of Thailand, through a royal co-operative project between the Thai 
and the Danish governments. During the following decades the dairy cattle 
population and the milk production increased but not sufficiently to meet the 
increasing market demand for milk and milk products. Therefore, since the early 
1990s, the Royal Thai government has encouraged farmers to start small holder 
dairy farms in other parts of the country, including the north-eastern provinces. 
Initially dairy cattle were introduced from central Thailand but as the numbers 
were inadequate, pregnant cows and heifers were imported from several other 
countries, mainly Australia and New Zealand. In 2005, the total number of dairy 
cows in Thailand was 478 386, a 3.5-fold increase since 1989. The average size of 
a dairy herd in the country is 9 milking cows/herd and the mean daily milk 
production is 9.6 kg/cow (DLD, 2004).  
 
Khon Kaen, Udorn Thani and Sakon Nakorn provinces are situated in north-east 
Thailand (map in Paper I). There are 14,027 dairy cattle in 1,100 herds in these 
provinces that sell their milk to 9 milk collection centres (MCs). In general, the 
main issues that concern dairy farmers are sub-optimal milk production, high 
somatic cell counts, reproductive failure and health problems. These problems are 
due to a combination of causes such as humid hot weather, nutritional 
insufficiency and infectious diseases.  
 
Infection with bovine viral diarrhoea virus and bovine 
herpesvirus type 1 in cattle 
Bovine viral diarrhoea virus (BVDV) and bovine herpesvirus type-1 (BHV-1) 
infections are spread in cattle populations all over the world. Serological surveys 
have revealed a high prevalence of antibodies to both BVDV and BHV-1 in the 
cattle populations of many countries including Thailand (Virakul et al., 1997; 
Houe, 1999; Straub, 2001; Moennig, Houe & Lindberg, 2005; Solis-Calderon, 
Segura-Correa & Segura-Correa, 2005). 
 
Infections with BVDV and BHV-1 cause losses from reproductive failures and 
increase the severity of secondary infections by other pathogens (Gibbs & 
Rweyemamu, 1977; Potgieter et al., 1984a; Duffell & Harkness, 1985; Fray, Paton 
& Alenius, 2000; Straub, 2001 ;Ackermann & Engels, 2006).  Effective control of 
BVDV and BHV-1, therefore, not only reduce the economic losses in production 
but also can prevent the suffering from disease and thus improve animal welfare. 
Since Thailand has signed the Free Trade Agreement with intensive milk 
production countries such as Australia and New Zealand, Thai dairy farmers must 
in order to be competitive improve both the dairy production and animal welfare. 
To achieve these aims, control programmes for infectious diseases are needed. At 
present, brucellosis, paratuberculosis and bovine tuberculosis are in eradication   10
schemes (Bureau of Disease Control and Veterinary Services, 2006) while foot 
and mouth disease, haemorrhagic septicaemia and anthrax are controlled by 
vaccination. The cows in Thailand are usually artificially inseminated with frozen 
semen produced in the country by the government and by private artificial 
insemination (AI) stations. Imported semen from many other countries has also 
been used. BVDV and BHV-1 are controlled as suggested by the OIE (2005) in all 
government AI stations, but only in a few number of private stations. After 
January 2006, AI stations that do not follow the regulation should be regarded as 
illegal semen producers (Bureau of  Biotechnology in Livestock Production, 
2005). 
 
Before the introduction of control measures for BVDV and BHV-1 infections it 
is desirable to have knowledge of the epidemiology and impact of the infections in 
the region. This work in this thesis was conducted with the purpose to gain such 
knowledge about the epidemiology of BVDV and BHV-1 infections in small dairy 
herds in Thailand, as a background to future control efforts. 
 
Bovine viral diarrhoea virus 
The virus 
Bovine viral diarrhoea virus is a heterogeneous group of viruses of the family 
Flaviviridae grouped in the genus Pestivirus together with closely related classical 
swine fever virus (CFSV) and border disease virus (BDV) (Donis, 1995). The 
virus mainly infects cattle but infections among other animals such as swine, 
sheep, goat and wild animals are also reported ( Liess & Moennig, 1990; Nettleton 
& Entrican, 1995; Deregt et al., 2005;Vilcek & Nettleton, 2006). CFSV causes a 
contagious haemorrhagic disease of pigs of worldwide importance and BDV 
infects sheep causing principally reproductive disease (Vilcek & Nettleton, 2006).  
 
The virus genome is a single stranded positive sense RNA of approximately 
12.5 kb. It has a single open reading frame (ORF) that is flanked by a non-coding 
region (NCR) at the 5  and 3  ends. The ORF is translated into a polyprotein of 
about 4000 amino acids, which is co- and post-translationally processed by 
cellular and viral proteases. The mature viral proteins are arranged as follows: 
NH2-N
pro, C, E
rns, E1, E2, p7, NS2-3, NS4A, NS4B, NS5A and NS5B-COOH 
(Meyers & Thiel, 1996; Ridpath, 2005). The 5 NCR, N
pro, E
rns, E2 and NS2/3 
genome regions have been used to identify pestiviruses, by means of reverse 
transcription-polymerase chain reaction (RT-PCR) complemented by sequencing 
for phylogenetic analysis.  In particular, the 5  NCR and N
pro regions show a high 
degree of conservation among pestiviruses, making them suitable for detection of 
a broad range of viruses and for strain discrimination studies (Hofmann, 
Brechtbuhl & Stauber, 1994; Becher et al., 1997;1999). The E2 protein is a highly 
genetically and antigenically variable glycoprotein and possesses neutralising 
epitopes and thus is used to study the molecular and serological diversity of 
BVDV ( Bolin et al., 1988; Corapi, Donis & Dubovi, 1990; Ridpath, Bolin & 
Dubovi, 1994; Becher et al., 2003). The protein E
rns remains intracellular and is 
secreted from infected cells and can be found free in the serum of primary and 
persistently infected (PI) animals, which gives it the potential to be used as   11 
diagnostic antigen (Brownlie, Thompson & Curwen, 2000). The NS2-3 are 
conserved and strongly recognized by monoclonal or polyclonal antibodies 
(Donis, Corapi & Dubovi, 1991), and these proteins are therefore used in antigen 
detection tests (Sandvik, 2005).  
 
1. Genotypes 
There are two genetically distinct types of BVDV, BVDV-1 and BVDV-2, which 
may be differentiated from each other and from other pestiviruses by monoclonal 
antibodies (MAb) directed against the E2 protein, or by genetic analysis of 
different regions of the genome (Pellerin et al., 1994; Paton et al., 1995b; Tijssen 
et al., 1996; Ridpath, 2003;).  Recently, an atypical isolate ‘HoBi’, which was 
found in a batch of pooled foetal calf serum, has been suggested to be of a third 
genotype of BVDV (Schirrmeier et al., 2004). 
 
Whereas BVDV-1 is the dominant genotype found worldwide, BVDV-2 appears 
to prevail mainly in the US and Canada. In Europe, Asia and South America, 
BVDV-2 has been reported sporadically ( Beer, Wolf & Kaaden, 2002; Flores et 
al., 2002; Park et al., 2004; Cranwell, Jones & Wakeley, 2005; Barros et al., 2006; 
Pizarro-Lucero et al., 2006). BVDV-2 infections have been associated with 
outbreaks of a severe acute infection that cause a haemorrhagic syndrome (Rebhun 
et al., 1989; Carman et al., 1998). However, subclinical infections are common 
with both genotypes. By molecular studies, BVDV-1 and BVDV-2 are further 
subdivided into at least 11 subtypes for BVDV-1 and 2 subtypes for BVDV-2 ( 
Vilcek et al., 2001; Flores, et al., 2002;). This heterogeneity seen among field 
isolates is a characteristic of RNA viruses, and is probably the result of high 
mutation rate during viral replication due to the error prone nature of viral RNA 
polymerase (Bolin & Grooms, 2004). Despite this, BVDV strains isolated at 
different points in time, from different animals within a herd show a high degree 
of homology, suggesting that BVDV is genetically stable after being introduced 
into the herd. This has led to the concept of  herd-specific strain of BVDV, and is 
though to be related to the presence of immunotolerant, persistently infected (PI) 
animals within the herd ( Paton et al., 1995a; Hamers et al., 1998; Vilcek et al., 
1999).  
 
2. Biotypes 
BVDV exists in two biotypes, the cytopathic (cp) and the non-cytopathic (ncp) 
and the classification is based on the ability of the virus to produce cytopathology 
or not in cultured cells. Cytopathic viruses may arise from ncp viruses after 
genetic alteration (i.e. insertion, duplication or rearrangements) within the region 
encoding the NS2/3 protein. The molecular changes result in expression of a NS3 
protein ( Brownlie, 1990; Meyers & Thiel, 1996; Baroth et al., 2000; Kümmerer et 
al., 2000;Becher et al., 2002). Cytopathic biotypes have only been isolated in 
connection with outbreaks of mucosal disease (MD). The ncp biotype is 
commonly found in nature and causes persistent infection in animals. For 
establishment of a persistent infection ncp BVDV escape the cellular defence 
mechanisms by turning off common responses to virus infection such as apoptosis 
and/or suppress induction of interferon and production of the Mx protein   12
(Bendfeldt, Grummer & Greiser-Wilke, 2003; Peterhans, Jungi & Schweizer, 
2003; Schweizer et al., 2006).  
 
Transmission of BVDV 
Persistently infected animals shed large quantities of BVDV throughout their lives 
and are the key transmitters of the virus. The main transmission route in infected 
herds is direct contact with a  PI animal (Bolin, 1990; Duffell & Harkness, 1985; 
Fray, Paton & Alenius, 2000; Lindberg & Alenius, 1999; Niskanen et al., 2000; 
Tråvén et al., 1991). Indirect transmission usually occur when virus is well-
preserved within the vehicle, e.g. in frozen semen from PI and acutely infected 
bulls, contaminated embryos or contaminated injection fluids. The potential for 
such a spread, even over the continents, is high ( Schlafer et al., 1990; Kirkland et 
al., 1991; Falcone, Tollis & Conti, 1999;Barkema et al., 2001; Givens et al., 2003; 
Niskanen & Lindberg, 2003; Schirrmeier, et al., 2004; Stringfellow et al., 2005). 
Indirect transmission by other means such as common calving pens, insects and 
examination glove, has only been shown experimentally, and only where the 
initial contact was PI ( Tarry, Bernal & Edwards, 1991; Gunn, 1993; Lang-Ree et 
al., 1994; Mars, Bruschke & van Oirschot, 1999; Niskanen & Lindberg, 2003 
;Lindberg et al., 2004).  
 
Acutely infected animals do not seem to play any substantial role in the 
transmission of BVDV (Niskanen, et al., 2000; Niskanen, Lindberg & Tråvén, 
2002). If the infected animals are not in the early stage of pregnancy, there is little 
chance of the virus persisting and those animals seem to be dead-ends of the 
infection. 
 
Clinical manifestation of BVDV  
BVDV causes a wide spectrum of clinical manifestations ranging from subclinical 
disease to the apparently always fatal form known as mucosal disease (MD). The 
clinical response to the infection depends on multiple interactive factors including 
the biotype and/or genotype of the virus, and the immune and pregnancy status of 
the host.  
 
1. Infection in non-immune non-pregnant animal 
Acute BVDV infections in non-immune cattle with BVDV are usually subclinical. 
However, the consequence of such infections is an immunosuppression (Chase, 
Elmowalid & Yousif, 2004), which predisposes the animal to infections with other 
pathogens ( Potgieter et al., 1984b; Baker, 1995; Potgieter, 1997; Graham et al., 
1998;de Verdier Klingenberg, Vagsholm & Alenius, 1999). The decrease in  milk 
yield, high bulk milk somatic cell count and increased risk of clinical mastitis in 
dairy cows are associated with BVDV infections are also believed to be caused, at 
least in part, by this immunosuppressive effect ( Niskanen et al., 1995; Lindberg & 
Emanuelson, 1997; Waage, 2000 ; Beaudeau et al., 2004; 2005).  
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2. Congenital infection  
In the first trimester of pregnancy, BVDV infection may result in foetal death, 
followed by abortion or mummification (Bielefeldt-Ohmann, 1995). Essentially, 
all foetuses surviving this period are born PI, with specific immunotolerance to the 
persisting virus (Brock & Chase, 2000). The final stages of organogenesis of the 
nervous system and eye occur during the second trimester and are susceptible to a 
disruption caused by viral replication. Resultant congenital defects include lens 
opacity, blindness, retinal dysplasia, cataracts, cerebellar hypoplasia and 
hydrocephalus. A stillborn calf is another sequel to a congenital infection in the 
second trimester. After 125 days of pregnancy the foetal immune system has been 
developed and can produce neutralising antibodies and eliminate the virus. At 
birth immunocompetent calves are virus-negative and antibody-positive (Moennig 
& Liess, 1995 ; Graham, 2001).  
 
3. Persistent infection  
Only transplacental infections by ncp biotypes during the first trimester cause the 
birth of PI calves (Charleston et al., 2001). After delivery, the PI calves have a 
specific immunotolerance to their persisting BVDV and do not exhibit any 
detectable antibody or T cell response to the virus (Collen et al., 2000). The 
clinical signs vary from the apparently normal health to unthriftiness and most of 
these calves die or are slaughtered due to disease. Between 1 to 2% of cattle are PI 
with BVDV in most countries with an intensive beef and dairy production (Houe, 
2005). The total losses from BVDV infections in such endemic infected countries 
due to e.g. death of calves, abortion and subclinical disease have been estimated to 
be in the range of 10 – 40 million $ per million calving (Houe, 2003). Therefore 
infections with BVDV must be regarded as a serious animal welfare problem in 
many countries all over the world.   Some PI calves can survive until maturity and 
if they are retained for breeding, their offspring is always PI but often fails to 
survive. PI bulls can produce semen of an acceptable quality, but may be 
associated with infertility (Moennig & Liess, 1995). However, Voges et al.(1998) 
report a case of a bull that was strongly sero-positive and non-viraemic but 
persistently shed the virus in the semen. This condition is thought to arise when 
bulls become infected at puberty, i.e. during the formation of the immunological 
‘blood-testes’ barrier, thus allowing the virus to replicate within the testes and 
evade immune surveillance ( Voges, et al., 1998; Fray, Paton & Alenius, 2000).  
 
4. Mucosal disease 
Only PI cattle are at risk of developing MD (Bolin, 1995b; Brownlie, Clarke & 
Howard, 1984; Roeder & Drew, 1984). Mucosal disease is characterised by a high 
death rate (100%) usually occurring within 1-2 weeks after the onset of clinical 
signs. Post-mortem examinations reveal erosions in the mucosa at various sites 
along the gastrointestinal tract (Baker, 1987). The cp biotypes are always found 
together with the homologous ncp biotype that persists in the affected animal. The 
cp strain can be of exogenous origin (i.e. be introduced through experiments or 
vaccines) or arise de novo by a genetic change in the resident ncp virus ( Ridpath 
& Bolin, 1995; Meyers & Thiel, 1996; Fritzemeier et al., 1997).  
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Laboratory diagnosis of BVDV infections 
The diagnostic assays, are in general, aimed to detect virus specific antibodies as 
an indication of exposure to BVDV, and/or aim at detection of infectious virus or 
viral components as an indication of current infection (review in: Sandvik, 2005) 
 
1. Detection of immune response against BVDV 
Primary infection in immunocompetent animals results in seroconversion after 
approximately three weeks (Howard, 1990). The antibody levels rise slowly, until 
a plateau is reached 10–12 weeks after infection and BVDV will probably be 
detected for the rest of the life of host (Brownlie et al., 1987; Fredriksen et al., 
1999). Different serological tests have been adopted for BVDV serology and the 
widely used sensitive tests are the virus neutralisation test and the enzyme linked 
immunosorbent assays (ELISAs).  
 
1.1 Virus neutralisation test  
The virus neutralisation (VN) test is the gold standard test for the detection of 
BVDV, CSFV and BDV antibodies because of its high sensitivity and specificity. 
The antibodies detected by the VN are predominantly against E2, which may 
result in different titres depending on which virus strain is used in the assay ( 
Jones et al., 2001; Couvreur et al., 2002). No single strain is ideal for all 
circumstances. For detection of antibodies to BVDV, a strain that detects the 
highest proportion of serological reactions in the local cattle population should be 
selected. Many laboratories use highly laboratory-adapted cp strains, such as 
Oregon C24V and NADL, even though immune labelling techniques are now 
available that allow detection of neutralisation of ncp strains. The output is based 
on the highest serum dilution that inhibits replication of a quantified amount of the 
challenge virus. However, the test is laborious and takes 5–6 days to perform, 
requires experienced staff and well equipped laboratories, reagents and cell culture 
free from contamination of pestivirus. It is therefore mostly used as a reference 
test for back-up and calibration purposes (Sandvik, 1999; 2005). It is also a crucial 
test to be able to differentiate, by use of cross neutralisation, the serological 
response in animals infected with other pestiviruses.  
 
1.2 The enzyme-link immunosorbent assays (ELISA)  
For testing of large number of samples, ELISA has many advantages over the VN. 
The test is independent of cell cultures and challenge viruses, gives a test result 
within a few hours, is relatively inexpensive both to establish and run, and is 
suitable for automation. There are two format of ELISA, the indirect and the 
blocking or competitive type, which are used for detection of antibodies in milk, 
blood plasma and serum samples (Howard, Clarke & Brownlie, 1985; Katz & 
Hanson, 1987; Niskanen et al., 1991; Paton et al., 1991; Schrijver & Kramps, 
1998). Indirect ELISA kits often use the whole BVDV as antigen for measuring 
antibody response against the full spectrum of immunogenic BVDV proteins.   
Blocking ELISA kits may use individual viral proteins and MAb, which may be a 
limitation (or advantage) since e.g. some ELISA tests have not been able to detect 
any antibodies in animals vaccinated with e.g. inactivated vaccines (Graham et al., 
2003).  
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The determination of the level of antibodies in pooled samples as bulk tank milk 
and ‘spot test’ can give a useful indication of the BVDV status of a herd ( 
Niskanen, et al., 1991;Niskanen, 1993; Houe et al., 1995; Paton et al., 1998; 
Lindberg & Alenius, 1999; Pritchard, 2001; Valle et al., 2005).  In addition, the 
immune response in pregnant cows, measured with an indirect ELISA can also be 
used to predict the BVDV status of their foetuses since in late pregnancy the dam 
with a PI foetus often has a markedly higher antibody response than does a cow 
carrying an uninfected foetus (Alenius et al., 1992; Brownlie et al., 1998; 
Lindberg et al., 2001).  
 
2. Detection of BVDV  
In principle, there are three different methods of detecting the virus or viral 
components: virus isolation in cell culture, detection of viral antigens and 
detection of viral nucleic acid. In primary infected animals, BVD virus and antigen 
can be detected in blood from the first couple of days to around two weeks after 
infection whereas viral RNA could be detected even longer ( Sandvik, Fredriksen 
& Løken, 1997; Bruschke et al., 1998; Ellis et al., 1998). In PI animals, BVDV 
antigen can be detected in sera and tissue samples during the whole life after 
maternal antibody has disappeared.  
 
2.1 Virus isolation (VI) in cell culture 
The virus may be isolated in a number of bovine monolayer cell cultures 
particularly in primary or secondary bovine cultured cells e.g. kidney, lung, testis 
or turbinate cells (Edwards, 1990; Saliki et al., 1997). Buffy coat cells or serum 
and semen are suitable for isolation of the virus from live animals. Maternal 
antibodies may however interfere with the VI in young calves. For detection of cp 
strains, the cells are inoculated with samples and checked for a cytopathic effect. 
For ncp strains, an immune labelling i.e. immunoperoxidase technique (IPX), 
described by Meyling (1984), in the final step is necessary. Virus isolation is an 
essential back-up and reference test for other indirect methods for identification of 
PI animals, and should be available as a confirmatory test for laboratories that use 
other tests to detect BVDV indirectly. 
 
2.2 Detection of viral antigens 
The antigen-capture ELISA is based on either MAb specific to one or more viral 
antigens for both capture and detection of antigen, or a combination of polyclonal 
and MAbs (Fenton et al., 1991; Mignon et al., 1992; Shannon, Mackintosh & 
Kirkland, 1993; Shannon et al., 1991). It is essential that these MAbs recognise all 
antigenic variants of BVDV circulating in the bovine population to be tested. In PI 
animals, BVDV antigens can be readily be detected in tissue sections, such as skin 
biopsies, by immunohistochemical staining ( Thür, Zlinszky & Ehrensperger, 
1996; Spagnuolo-Weaver et al., 1997; Brodersen, 2004; Loneragan et al., 2005). 
Although more labour intensive than antigen ELISAs, this method can be applied 
to detect viral antigen in young PI calves, which otherwise could have tested 
negatively by VI or antigen ELISAs due to inhibition by maternal antibodies 
(Zimmer et al., 2004) 
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2.3 Reverse transcription –polymerase chain reaction  
To detect viral nucleic acid of BVDV, reverse transcription-polymerase chain 
reaction (RT-PCR) has been adapted and used widely. Detection of RNA by RT-
PCR comprises of four different steps: extraction of RNA, reverse transcription to 
complementary DNA, primer-directed amplification and lastly detection of 
amplified products. In the past, each step was run separately which was time-
consuming and increased risk of contamination of samples, especially when many 
samples are processed together. The closed one-tube TaqMan RT-PCRs combine 
the last three steps in a single tube, and by eliminating the need for gel 
electrophoresis, the risk of carry-over contamination with the previously amplified 
products and false positives is greatly reduced. The RT-PCR technique has been 
used to detect BVDV in various samples such as foetal fluids, tissues, serum, 
semen, cell cultures and whole blood (Belák & Ballagi-Pordány, 1991; Da Silva et 
al., 1995; Letellier et al., 1999; Lindberg et al., 2002; Stokstad et al., 2003). The 
nested RT-PCR is another modified techniques of  RT-PCR which re-amplifies the 
first PCR product and therefore increases test sensitivity (Gruber et al., 1994). The 
development of the real-time PCR provides the capability to quantify the virus in 
pooled blood serum, and to genomic typing by using specific sets of primers and 
probes (Letellier & Kerkhofs, 2003; Baxi et al., 2006; Willoughby et al., 2006).  
 
Control of BVDV  
Different disease control schemes of BVDV are used in different countries. They 
can be divided into non-vaccination and vaccination schemes. 
 
1. Non-vaccination schemes 
Eradication programmes are in progress in a number of European countries 
including Sweden, Norway, Denmark, Finland and Austria with successful 
performance (Bitsch, Hansen & Ronshølt, 2000; Hult & Lindberg, 2005; Rikula et 
al., 2005; Rossmanith, Janacek & Wilhelm, 2005; Valle, et al., 2005). Based on 
the Scandinavian experience, effective protocols have been described for herd 
screening followed by identification and removal of PI animals and/or certification 
of a BVDV-free status (Lindberg & Alenius, 1999). In accordance with the 
programme protocol, herds may be certified free from infection based on low 
levels of or undetectable antibody in repeatedly taken bulk milk samples or 
absence of serum antibodies in small numbers of home-bred young animals 6-18 
months old, taken at least twice with a more than 6-month interval (Alenius, 
Lindberg & Larsson, 1997). High levels of bulk milk antibody and seropositivity 
in a spot test, by contrast, indicate an active BVDV infection. This is often in the 
form of one or more PI animals present in the herd. Identification and removal of 
PI animals in a safe and effective way from a herd requires individual testing of all 
animals in the herd (Larsson et al., 1994). At all stages of the procedure the 
farmers receive information and advice, based on the current knowledge of the 
BVDV status of the herd (Lindberg & Alenius, 1999). The principal risk factors 
for introduction or reintroduction of an infection are purchase of PI animals or 
dams carrying PI foetus or contact with PI cattle from an infected herd (Alenius, et 
al., 1992; Alenius, Lindberg & Larsson, 1997; Bitsch, Hansen & Ronshølt, 2000).   17 
Management procedures need also to be reviewed in order to ensure that an 
adequate biosecurity is provided and that any reintroduction is detected and dealt 
with rapidly (Graham, 2001; Valle, et al., 2005).  
 
2. Vaccination schemes 
The primary goal of vaccination is to induce a sufficient level of immunity 
sufficient to prevent transplacental infection of foetuses and subsequent birth of PI 
animals. The combination of vaccines and systematic identification, and removal 
of PI animals can be used to eradicate BVDV from herds. The vaccination ensures 
that the herd protection due to the natural infection wanes; it is replaced by a 
vaccine-induced immunity (Moennig et al., 2005). However, there are difficulties 
in implementing such vaccination programmes (Graham, 2001). Notably, in 
countries that have made extensive use of live BVDV vaccines, such as US, 
Canada, Belgium, Germany and Japan, a high presence of BVDV type 2 infections 
has been reported (Pellerin, et al., 1994;Bolin, 1995a; ; Wolfmeyer et al., 1997; 
Letellier, et al., 1999; Ridpath et al., 2000; Nagai et al., 2001; Tajima et al., 2001). 
This is in contrast to results obtained from studies performed in countries that have 
not used live BVDV vaccines, such as Sweden, UK, New Zealand and Australia. 
Consequently, there appears to be an association between the use of live BVDV 
vaccines and the presence of type 2 BVDV strains in the cattle populations 
(Lindberg and Alenius, 1999). Furthermore, live cp vaccines can induce MD in PI 
animals by recombination between vaccine virus and the ncp-persistent virus ( 
Fritzemeier et al., 1995; Ridpath & Bolin, 1995; Becher, Orlich & Thiel, 2001). 
Moreover, modified live vaccine may cause reproductive disease, 
immunosuppression and ovarian lesions (Bolin, 1995a; Grooms, Brock & Ward, 
1998). Inactivated BVDV vaccines are safe to use in pregnant animals but their 
efficacy and potency, e.g. to prevent congenital infection seems limited (van 
Oirschot, Bruschke & van Rijn, 1999; Graham et al., 2004) . In Germany, a 
BVDV control programme based on testing and, as an option a two-step 
vaccination (with inactivated and live vaccines) is underway (Moennig, et al., 
2005; Moennig, Houe & Lindberg, 2005).  
 
Bovine herpesvirus type 1  
The virus 
Bovine herpesvirus type 1 (BHV-1) is a member of the family Herpesviridae, 
subfamily Alphaherpesvirinae and is an important pathogen of cattle (Ackermann 
& Engels, 2006). By restriction enzyme analysis, two subtypes of BHV-1 have 
been described. BHV-1 subtype 1 represents strains that cause respiratory disease, 
infectious bovine rhinotracheitis (IBR), whereas subtype 2 includes strains that 
cause genital diseases, e.g. infectious pustular vulvovaginitis (IPV) and  infectious 
balanoposthitis (IBP) (Engels, Steck & Wyler, 1981; Radostits et al., 2000). 
Metzler et al. (1985) used DNA restriction enzyme analysis to further classify 
subtype 2 into 2a and 2b. Subtypes 1 and 2a have been isolated from aborted 
foetuses, whereas the less virulent subtype 2b has not been reported to be 
associated with abortion (Edwards, Newman & White, 1991; Miller, Whetstone &   18
Van der Maaten, 1991). By conventional serological assays there is however only 
one antigenic serotype of BHV-1. Infection with BHV-1 has also been reported to 
occur in wild ruminants and swine (Varady, Tuboly & Derbyshire, 1994 ; 
Radostits, et al., 2000).  
 
Transmission of BHV-1 
The virus is most commonly transmitted by close contact between infected and 
susceptible animals by means of trade (Nylin, Madsen & Ronshølt, 1998;  Hage et 
al., 2003). Indirect transmission may occur via contaminated equipment and 
semen ( van Oirschot et al., 1993; van Oirschot, 1995; Hage, et al., 2003).  
 
Clinical manifestation of BHV-1 
Infectious bovine rhinotracheitis (IBR) usually occurs as a subclinical respiratory 
infection but also can be a cause of a severe disease. Morbidity and mortality may 
reach 100% and 10%, respectively, particularly if complication occurs (Radostits, 
et al., 2000). Unilateral or bilateral conjunctivitis, often with profuse lacrimation, 
is a common clinical sign of the infection although bronchitis and bronchiolitis 
have occasionally been observed. In most cases pulmonary pathology has not been 
found unless secondary bacterial bronchopneumonia occurs (Radostits, et al., 
2000). Secondary bacterial infections with, for example, Pasteurella spp., can give 
rise to more severe clinical signs due to deeper airways being affected. Abortions 
may occur in the course of IBR during the third trimester of pregnancy (Murphy et 
al., 1999). Where natural mating is practiced, genital infection can lead to pustular 
vulvovaginitis or balanoposthitis. These are characterized by mild to severe 
necrotic lesions in the vaginal or preputial mucosae. After artificial insemination 
with infected semen, endometritis can arise (Kendrick & McEntress, 1987). 
Uncomplicated cases of respiratory or genital disease caused by BHV-1 are 
usually last 5-10 days.  
 
As a member of the herpesvirus family, BHV-1 can cause latency. The sciatic 
and trigeminal ganglia and the tonsils are the sites of latency after genital and 
respiratory disease, respectively (Ackermann, Peterhans & Wyler, 1982; 
Ackermann & Wyler, 1984; Winkler, Doster & Jones, 2000). Latency allows the 
virus to persist, so that the introduction of a latent infected carrier into a non-
infected herd is the principal way for the virus to spread. The persisting BHV-1 
can be reactivated and re-excreted by several stimuli, including transport, 
parturition, and treatment with glucocorticoids (Thiry et al., 1987). When BHV-1 
is reactivated, the virus establishes a new life cycle of replication and can be 
transmitted to susceptible animals (Bitsch, 1973; van Oirschot, et al., 1993). 
 
Laboratory diagnosis of BHV-1 infections 
The BHV-1 infection can be identified by detection of a specific antibody 
response and detection of the virus or viral antigens.  
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1. Detection of immune response against BHV-1  
Specific antibodies to BHV-1 can be first detected at 7 to10 days post-infection. 
After the acute phase and during latency, BHV-1-infected cattle are mainly 
detected by the presence of specific antibodies to BHV-1. Virus neutralisation 
tests and various ELISAs are usually used for detecting antibodies against BHV1 
in serum and ELISA tests appear to gradually be replacing VN tests. Several types 
of BHV-1 ELISA tests are commercially available and most of them are also 
suitable for detecting antibodies in milk. The test on bulk milk, used with an 
appropriate cut-off value, has been reported to estimate the prevalence of BHV-1 
in a herd (Pritchard, 2001). However, data from individual or pooled serum from 
non-milking groups will more precisely provide the herd’s status. In addition, 
some ELISAs can be used in conjunction with marker vaccines to detect infected 
cattle in a vaccinated population (van Oirschot et al., 1997; Wellenberg et al., 
1998).  
 
2. Detection of BHV-1  
The virus can be isolated from nasal swabs taken during the acute phase of the 
infection, semen from infected bulls and from various organs collected at post-
mortem (Radostits, et al., 2000). However, the isolation of BHV-1 from an animal 
does not mean that the virus is the cause of the disease outbreak because it may be 
a latent virus that has been reactivated under stress conditions. A confirmatory 
laboratory diagnosis must be made on a group of animals and must be 
accompanied by either seroconversion from negative to positive or a fourfold or 
higher rise of antibody titres to BHV-1.  
 
2.1 Virus isolation in cell culture 
Primary and secondary bovine kidney, lung, testis, turbinate, trachea or foetal lung 
cells and established cell lines are all suitable for virus isolation. The selected cells 
are inoculated with the samples and are observed daily for cytopathic effect. An 
alternative method of virus identification is the direct demonstration of BHV-1 
antigen in infected cells by an immunofluorescence or conjugated 
immunoperoxidase assay based on monoclonal antibodies (Kaashoek et al., 1994).  
 
2.2 Detection of viral antigens  
The fluorescence antibody test is used during the acute stage of the disease and is 
appropriate for detecting presence of the virus in nasal, ocular and genital swabs. 
Scraping of mucosal lesions or white plaques from the nasal mucosa should give a 
positive and rapid result in most acute cases. However, the sensitivity of this 
procedure is lower than that of virus isolation (Edwards, Chasey & White, 1983). 
  
2.3 Polymerase chain reaction (PCR)  
The PCR has been developed to detect BHV-1 DNA in infected semen samples ( 
van Engelenburg et al., 1993; 1995; Vilcek et al., 1994; Xia, Yason & Kibenge, 
1995; Grom et al., 2006). The PCR assay is more sensitive and independent of the 
quality of the sample than either virus isolation or the fluorescent antibody tests, 
and it is also faster than virus isolation (Vilcek, et al., 1994; Moore, Gunn & 
Walls, 2000;  Grom, et al., 2006).   20
Control of BHV-1 
BHV-1 is included in the list B disease of the OIE and it is therefore a target for 
international legislation and control. At the national/regional/herd level, the virus 
is either controlled systematically by ‘test-and-cull’ or ‘test-and-removal’ with or 
without vaccination schemes.  
 
‘Test and cull’ without vaccination has been used with a high degree of success 
in countries such as Denmark, Finland, Austria, Sweden and Switzerland 
(Ackermann et al., 1989;1990; Nylin, Madsen & Ronshølt, 1998; Kofer, Wagner 
& Deutz, 1999; Vonk Noordegraaf et al., 2000;  Paisley, Tharaldsen & Jarp, 
2001). For systematic schemes, biosecurity is the main important factor for the 
successful eradication of BHV-1. Biosecurity of BHV-1 is based on hygienic 
measures. Ideally, a 4-week quarantine period is imposed for introduced cattle to a 
free herd. Only seronegative animals after the quarantine are can be admitted into 
the herd. Once an animal is infected it has been regarded as a lifelong potential 
shedder of BHV-1 and therefore can be culled or removed from the herd. To 
minimise the risk of introducing the virus into BHV-1-free herds or AI centres, the 
recognition and removal of animals that are latent carriers is important in control 
programmes and in international trade activities (Kramps et al., 1996). Control 
with testing and vaccination has been applied in e.g. Germany, Belgium, Hungary, 
a province in Italy and the Netherlands  (Tanyi & Varga, 1992; Nardelli et al., 
1999;Limbourg et al., 2002;Trapp, Konig & Beer, 2003; Vonk Noordegraaf et al., 
2004). However, not a single country that has included vaccination has yet 
succeeded to eradicate BHV-1 (Ackermann & Engels, 2006).  
 
Although clinical disease induced by BHV-1 can be reduced by vaccination, 
latent infections cannot be prevented (Kaashoek, et al., 1994). Another 
disadvantage of conventional vaccines is their interference with routine serological 
diagnostic tests. Marker vaccines reduce this problem but the serology must be 
based on compatible diagnostic tools (Kaashoek, et al., 1994;Babiuk, van Drunen 
Littel-van den Hurk & Tikoo, 1996; van Oirschot, et al., 1997;de Wit et al., 1998; 
Wellenberg, et al., 1998). 
 
In many countries no systematic action at all are taken on the herd or regional 
level to reduce the BVDV and BHV-1 infections, the prophylaxis is based on 
‘herd’s decision’ of using multivalent BVDV and BHV-1 vaccines. Furthermore 
in some countries, no action at all has been taken in the past to try to prevent these 
infections.    21 
Aims  
The overall aim of this study was to investigate the epidemiological pattern of 
BVDV and BHV-1 infections in dairy herds in Thailand. More specifically, the 
following aims were set: 
  
• To establish the prevalence and relationship between BVDV and BHV-1 
infections in dairy herds in northern and north-eastern Thailand (I).  
 
•  To study the incidence of BVDV and BHV-1 infections in a long-term study of 
dairy herds in north-eastern Thailand, both on an individual and herd level (II).  
 
• To evaluate the usefulness of different serological and virological methods for 
BVDV investigations in dairy cattle herds (I-V). 
 
• To characterize BVDV strains in Sweden and Thailand and to investigate 
whether such a molecular approach may help to trace routes of transmission (IV, 
V). 
 
• To discuss recommendations for a future control of BVDV and BHV-1 
infections in Thailand based on the performed studies.   22
Materials and methods 
Detailed description of material and methods are given in each paper.  
 
Study design 
Paper I & II 
In Paper I, 220 dairy herds were randomly selected during 2000-2001 from nine 
MCs: seven located in the north-eastern provinces; Khon Kaen, Udorn Thani and 
Sakon Nakorn (MC 1-7), and two in a northern province; Chiang Mai (MC 8-9). 
These herds represented approximately 20% of the dairy herds in the nine MCs 
(range: 10-36%). From this set of herds, a subset of 11 herds located in the Khon 
Kaen province (MC 1 and 2) was also selected. This selection was based on 
accessibility. Blood samples were collected from all cattle in these dairy herds and 
analyzed to detect the presence or absence of current infections. Bulk tank milk 
from the herds was collected at the day of blood collection.  In Paper II the 
sampling of these 11 herds was repeated in September 2003 and October-
November 2004. During 2002-2004, 186 herds were BTM collected four times 
from MC 1-7 in the north-eastern provinces. Among this group, 67 herds had been 
investigated in 2000. During the period, vaccination against BVDV and BHV-1 
still was not used in the study areas.  
 
Paper III 
A commercial E
rns capture ELISA (Herd Check BVDV Ag/Serum plus, IDEXX 
Laboratories, INC.) was evaluated in comparison with the VI test for detection of 
BVDV antigen in cattle sera. Two hundred-twenty cattle sera from routine 
submissions in the Swedish BVDV eradication programme were selected. 
According to the results from the IPX used within the routine diagnostics 
(Meyling, 1984) 90 of the sera were considered virus positive and 130 virus 
negative.  
 
To study the influence of passive immunity on the performance of the ELISA, 
23 serum samples were used from 9 PI calves born after a previously described 
experimental infection of pregnant heifers (Lindberg, et al., 2002). The samples 
were collected between day 0 (i.e. immediately after birth and before intake of 
colostrums) and day 11 post partum. Of the nine calves, five were given 
colostrums free from BVDV antibodies, and four were given colostrums from 
their respective antibody positive dams.  
 
The influence of heat inactivation was studied on a subset of 20 sera (10 virus 
positive and 10 virus negative) out of the 220 samples previously selected from 
the routine diagnostics. Each sample was divided in two parts, and one was heat 
inactivated at 56˚C for 90 minutes before further analysis. Heat inactivated and 
non-heated sera were then tested in parallel with the E
rns ELISA. 
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Paper IV 
In Paper IV, sera from individuals identified as virus-positive within the Swedish 
BVDV eradication programme between October 2002 and June 2004 were 
collected and stored at -20°C. During the 18 months, 329 individuals from 112 
herds were tested virus-positive and isolates from all positive samples were stored 
in the BVDV bank and used later for phylogenetic analysis.  
 
Diagnostic tests 
Indirect ELISA for BVDV 
A commercial indirect ELISA kit (SVANOVA Biotech AB, Uppsala, Sweden) 
was used to detect antibodies to BVDV in bulk milk and serum in Paper I and II, 
according to the instructions of the manufacturer. The corrected optical density 
(COD) level was calculated by subtracting the optical density (OD) for the control 
antigen from sample OD; (OD 
sample - OD 
control) = COD. In Paper I the Swedish 
system of classification and interpretation of the results of the BVDV antibody 
ELISA on bulk milk was used whereby herds are allocated into four different 
classes based on COD levels ( Niskanen, 1993; Lindberg & Alenius, 1999). The 
individual results were interpreted according to Juntti et al. (1987), i.e. sera with 
CODs ≥ 0.20 were considered positive.  
 
In Paper II, percent positivity (PP) was used instead of the CODs to minimize 
the effect of plate variability between analyses. The PP was calculated as 
followed: PP= COD 
sample / mean COD 
positive control x 100. Individual serum results 
were interpreted according to the manufacturer; i.e. sera with PP ≥ 14 were 
considered positive. The cut-off for PP-values in BTM samples that were able to 
classify herds with the highest accuracy was selected based on its sensitivity and 
specificity. The 95% confidence intervals (CI) of the sensitivity and specificity 
estimates, as well as positive and negative predictive values, were also calculated. 
All herd BTM samples were subsequently classified as positive for BVDV if the 
PP-value was higher than the selected cut-off (PP ≥  2). Additionally, BTM 
samples positive for BVDV was further differentiated as medium and high 
antibody herds; when the PP-value ranged between 13 – 30 and greater than or 
equal to 30, respectively, which correspond to BVDV class 2 and 3 in the Swedish 
BVDV eradication programme ( Niskanen, 1993; Jalali et al., 2005).  
 
Indirect ELISA for BHV-1  
A commercial indirect ELISA kit (SVANOVA Biotech AB, Uppsala, Sweden) 
was used in Paper I and II to detect antibodies to BHV-1 in bulk milk and in 
serum, according to the instructions of the manufacturer. The corrected optical 
density (COD) level was calculated before interpretation of the results by 
subtracting the optical density (OD) for the control antigen from sample OD (OD 
sample - OD 
control = COD). In Paper I, the results of the BHV-1 antibody ELISA on 
bulk milk were interpreted according to the Swedish IBR control programme, i.e. 
samples with CODs ≥ 0.05 were considered positive. In Paper II the cut-off value 
(PP  ≥ 3) for classification of positivity / negativity of bulk milk samples was   24
established in the same way as described for BVDV. The individual sera with 
CODs ≥ 0.20 were considered positive for antibodies to BHV-1.  
 
VN 
The neutralisation capacity of the serum samples was tested to the two accepted 
pestitivirus species; BVDV-1 (NADL), BVDV-2 (CVL-178003/GB-1987) and to 
the recently described atypical BVDV strain D32/00_’HoBi’. In Paper V, a border 
disease virus (BDV) strain (strain 137/4) was included in the test protocol. A 
volume of 50 µl of serial two-fold dilution, from 1:8 of heat inactivated sera were 
mixed in two to four wells in the microtitre plates with 50 µl with approximately 
100 TCID50 of respective pestivirus strain and incubated 1 hour at 37ºC in a 
humidified CO2 incubator. Approximately 15,000 bovine turbinate cells were 
added per well. After 3 days of incubation at 37ºC in a humidified CO2 incubator, 
the plates were fixed and dried before they were stained with immunoperoxidase 
technique as described by Meyling (1984).  
 
E
rns capture ELISA  
A commercial E
rns capture ELISA (Herd Check BVDV Ag/Serum plus, IDEXX 
Laboratories INC.) was evaluated in Paper III, and used to detect BVDV antigen 
in cattle sera in Paper I-II and V, according to the manufacturers’ instructions. The 
relative sensitivity and specificity of the E
rns  ELISA in relation to IPX was 
calculated and the degree of agreement between the IPX and the E
rns ELISA was 
measured by determining the kappa ratio. To estimate the effect of heat 
inactivation on the performance of the ELISA, the repeatability of the test before 
and after heat inactivation of the samples used the concordance correlation 
coefficient (Lin, 1989) and Bland-Altman plot (Bland & Altman, 1986).  
 
RT-PCR and genotyping 
In Paper IV, one isolate from each of the 112 infected herds was selected for 
amplification and sequencing. BVDV RNA was extracted from the supernatants of 
virus-infected cells using a fully automated one-step protocol. The target region, 
5´NCR was amplified as described by Elvander et al. (1998). A 237-nucleotide 
fragment of the 5´NCR, corresponding to position 135-371 of the BVDV-1 strain 
SD-1 (Deng & Brock, 1992), was used for phylogenetic analysis. Additional 
sequences representative of each known genetic subgroup of BVDV were 
obtained from the GenBank and included in the alignments. Phylogenetic trees 
were constructed using neighbour-joining. The robustness of the method was 
evaluated by bootstrap analysis.  
 
In Paper V BVDV RNA was extracted directly from the antigen positive serum. 
All other procedures were performed as described above. The phylogenetic 
analyses was done in the 183 nucleotides fragment of 5´ NCR, corresponding to 
position 160-341 of the BVDV-1 strain NADL (Colett et al., 1988). 
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Results and discussion   
A detailed description and discussion of the results are given in each paper.  
 
Prevalence of BVDV and BHV-1 infections in dairy herds in 
northern and north-eastern Thailand (Paper I) 
The results from BTM testing demonstrated a moderate level of exposure to 
BVDV and BHV-1 in the 220 studied dairy herds from the northern and north-
eastern Thailand, with prevalences of antibody-positive herds of 73 and 67%, 
respectively. One of the two MC from the northern province (MC 9) had low 
prevalences of BVDV (14%) and BHV-1 (2%) compared with 80% and 96% of 
the neighbouring MC 8. Demography and management practices were not studied 
but one distinguishing factor was that most herds in MC 9 were established about 
10 years earlier than the herds in MC 9. At the animal level the low within-herd 
prevalence of BVDV and BHV-1 in the 11 herds (24 and 5%, respectively), 
particularly among the young stock (15 and 0%, respectively), indicated a low 
prevalence of active BVDV infections and a low rate of reactivation of latent 
BHV-1. 
 
Evidence of a self-clearance process of BVDV infection (Paper II) 
The long-term study of the 186 dairy herds showed that the prevalence of BVDV 
positive herds decreased from 91% in 2002 to 72% in 2004 (χ
2  = 24.36, p  ≤ 
0.001). The prevalence of BVDV positive herds of the 67 herds decreased from 
94% in 2000 to 75% in 2004 (χ
2 = 9.54, p ≤ 0.01). Similarly, the proportion of 
class 3 BVDV herd of the 186 herds significantly decreased from 20% in 2002 to 
8% in 2004 (χ
2 = 12.9, p ≤ 0.001) and for the subset of 67 herds from 22% in 2000 
to 4% in 2004 (χ
2 = 6.08, p ≤ 0.025).  
 
The clearance process was also shown at the animal level in the 11 herds. In 
2001, all 11 herds had antibody-positive animals. A total of 83 antibody-positive 
animals were found with a mean seroprevalence of 24% (range 6-55%). During 
the study period the prevalence decreased in 9 out of 10 (90%) of the herds where 
all animals were sampled. The incidence rate was low among cattle in 10 out of 11 
herds. One herd, however, had a high seroconversion rate to BVDV and a 
viraemic calf was identified by a commercial E
rns capture ELISA. Genetic 
characterization (Paper V) showed that the calf was infected with a virus closely 
related the to atypical pestivirus strain HoBi that was recently detected by 
Schirrmeier et al. (2004), in a batch of foetal calf serum originating from Brazil. 
The comparative VN test strongly suggests that the seroconversions in these herd 
and two other herds were caused by the ‘HoBi’-like virus strain. Furthermore, a 
retrospective study indicated the virus has recently been introduced to the region.  
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Evidence of a self-clearance process of BHV-1 infection (Paper II) 
The prevalence of BHV-1 positive herds, based on 186 herds of MC 1-7, 
decreased significantly from 61% in 2002 to 48% in 2004 (χ
2= 6.24,  p ≤ 0.025). 
Over a longer time period the prevalence in the 67 herds decreased from 84% in 
2000 to 57% in 2004 (χ
2= 11.55, p< 0.001). The likelihood of herds free of BHV-
1 infection in 2002 being antibody positive in 2004 was 0.29 (21/73). On the other 
hand, the likelihood of seropositive herds becoming free of BHV-1 infection 
during the same period was 0.40 (45/113). There were 43 herds free of BHV-1 in 
both 2002 and 2003, and 37 herds of these remained free to the end of this study. 
Six herds became positive in 2004 but only one herd had a high PP value (PP=86) 
whereas the other five remained low (PP ranged from 3 to 15, mean 7.2). 
 
The incidence rate of BHV-1 in the 11 herds during 2001- 2004 was low. Only 
seven animals in three herds seroconverted during the study period and three of 
these seroconversions occurred in a herd totally free from antibody-positive 
animals. The four other seroconversions occurred in two herds with BHV-1 
infected animals present and that reactivated virus caused these infections cannot 
be excluded. However, based on this study and also  other studies (van Nieuwstadt 
& Verhoeff, 1983; Hage, et al., 2003), the risks of reactivation of BHV-1 infected 
animals probably have been greatly overestimated in the past (Pritchard, 1992 ; 
Kampa et al., 2004). One explanation might be that different strains of BHV-1 
have a higher tendency for reactivation than others.  
 
Herd characteristics such as low number of purchased animals, small herd size 
and low incidence of ongoing BVDV infections may also be beneficial for the 
self-clearance process of BHV-1. Furthermore treatments of cows with 
corticosteroids in Thai dairy herds are not a common practice.  
 
Since it has been calculated that the uncertainty of the yearly reactivation rate of 
latently BHV-1 infected animals greatly affects the eradication costs of BHV-1 
from a cattle population ( Vonk Noordegraaf et al., 2002; Ackermann & Engels, 
2006) this is an important area of research that needs to be studied in carefully 
controlled field studies or under well controlled experimental conditions.  
 
Relationship between BVDV and BHV infection (Paper I and II) 
There was a significant association between being antibody-positive to BVDV and 
being BHV-1-positive, at the herd level both in the initial study (Paper I) and the 
long-term study (Paper II). In the long-term study, the relationship between BHV-
1 antibody status and BVDV antibody status in the 186 BTM samples was highly 
significant at all four samplings. At an animal level, in the 11 closely monitored 
herds, there were 31 cattle that had antibodies to BHV-1 during 2001-2004. 
Seventeen of these were also seropositive to BVDV. One animal became infected 
with both viruses in 2004. The strong significant association between being 
antibody positive to the viruses, both at the herd and animal level, suggests that 
similar factors might be of importance for the risk of introduction of both these 
infections to dairy herds. Such a strong association on a herd level has also been 
reported from a study performed in the UK (Paton, et al., 1998). 
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One obvious risk factor, and probably the most important, is the introduction of 
dually infected cattle to a herd, while another risk factor is artificial inseminations. 
It was observed that all seven seroconversions to BHV-1 in the 11 herds occurred 
in animals older than 2 years (range 2-10 years) which had all been inseminated. 
For BVDV 14 cows that had all been inseminated seroconverted to BVDV. These 
seroconversions may have been caused by BHV-1 and/or BVDV contaminated 
sperm or by indirect transmission to the animals by the person performing the 
inseminations. However, the specific route could not be traced by the herd’s 
records because the animals were inseminated several times by different 
practitioners using different batches of semen, but this factor could not be ruled 
out. 
 
Use of indirect ELISA to estimate herd’s BVDV and BHV-1 
status (Paper I and II) 
In BVDV and BHV-1 eradication schemes, antibody testing of pooled milk and 
pooled serum sample has been used intensively in the Scandinavian countries as 
herd screening tests. In a non-vaccinated population a high antibody level in BTM 
using an indirect ELISA indicates a probability of the herd having been exposed to 
BVDV in the recent past. By contrast, an absence of antibodies indicates that the 
herd is free from the infection (Graham, 2001; Niskanen, 1993; Paton, et al., 
1998).  
 
In Paper I and II a commercial indirect ELISA (SVANOVA Biotech AB) was 
used to determine BVDV and BHV-1 infection status of the herds by BTM which 
yielded highly valuable information. The study of BTM in Paper I was based on a 
COD classification system that is used in the Swedish BVDV and BHV-1 
eradication programmes (Lindberg & Alenius, 1999). 
 
In Paper II, PP was used instead of COD values to reduce the effect of inter-
plate variability. The test characteristics for the indirect BVDV ELISA at a cut-off 
for PP of 2 showed a sensitivity of 100% (CI 88-100%) as 28 BTM samples from 
herds with seropositive lactating cows all tested positive. The specificity of the test 
was 80% (CI 28-100%) as one false positive (PP = 2.7) was found among the five 
negative lactating groups. The evaluated cut-off at 2 PP  is the same as the cut-off 
value used in the Swedish BVDV-eradication scheme for BVDV class 0 herds 
(Jalali, et al., 2005; Niskanen, et al., 1991). The corresponding cut-off value for 
the indirect BHV-1 ELISA (SVANOVA Biotech AB) was 3 PP which is close to 
the COD value at 0.05 that is used in the Swedish monitoring programme for 
freedom of BHV-1 infection.  
 
Comparative virus neutralisation test for BVDV (Paper II and V) 
Individual susceptible cattle respond with higher neutralising titre to the genotype 
of BVDV with which they have been infected and with comparative lower titres to 
other genotypes (Jones, et al., 2001;Couvreur, et al., 2002; Schirrmeier, et al., 
2004). The results of the comparative neutralisation test in Paper II & V indicated 
the need to include the ‘HoBi’ strain in a reference panel. If the HoBi had not been   28
included in the neutralisation tests, it would have been hard to explain the 
serological pattern against BVDV type 1 and type 2 found in the individual 
animals in three of the herds that seroconverted with more than fourfold higher 
titres against HoBi compared to BVDV type 1 and 2.  
The low titre to the HoBi, but high against BVDV-1, in all analysed sera 
collected in 2001 implies that the atypical virus was recently introduced during 
2002-2003. Thus the test can be used to investigate retrospectively which 
genotype of BVDV an animal has most probably been infected with.  
 
Antigen ELISA (Paper III) 
In a regional or national control programme for BVDV it is important that the tests 
used are robust, have a high sensitivity and specificity and have been thoroughly 
evaluated for use on routine samples submitted to the laboratory. In Paper III the 
results from 220 field serum samples in this study showed the ability of the 
commercial E
rnsELISA (IDEXX Laboratories, INC.) to detect BVDV antigen in 
cattle serum. The test has 100% relative sensitivity and specificity when compared 
to the virus isolation. Heat inactivation did not disrupt the ELISA performance. 
An atypical pestivirus (Th/04_KhonKaen) in heat inactivated calf serum was 
detected by the test.  
 
RT-PCR and genotyping (Paper IV and V) 
Molecular epidemiology uses molecular data as the basis for investigations to trace 
sources of infection. In Paper IV, one isolate from each of the 112 infected herds 
was selected for amplification and sequencing. Phylogenetic analysis showed that 
the BVDV strains that circulate in Sweden belong to genotype 1: subtype 1a 
(n=7), 1b (n=28) or 1d (n=77), according to the nomenclature used by Vilcek et 
al.(2001), confirming previous results. Alignment and comparison of the 5  NCR 
fragment revealed a total of 67 different sequences, and among these 48 were 
unique for a single herd. Nineteen sets of identical sequences originated from 
isolates from between 2 and 14 different herds. The percentage of identity between 
pairs of sequences varied between 95-100% within subtypes and between 85-91% 
between subtypes, corresponding to differences of between 0-13 nucleotides (nts) 
and 21-35 nts, respectively.  In three cases, suspected routes of transmission were 
supported by the phylogenetic analysis. Since this paper was published, more 
isolates have been sequenced and the method helped to both strengthen suspected 
routes of transmission and also rule out suspicions.  
 
The antigen positive calf serum from Thailand was analysed in Paper V. The 
analysis demonstrated that the detected virus (Th/04_KhonKaen) was closely 
related to D32/00_’HoBi’. Pairwise evolutionary distance within the studied 
fragment between Th/04_KhonKaen and D32/00_HoBi was estimated at 0.08. The 
range of pairwise distances between Th/04_KhonKaen and other species within 
the genus Pestivirus, including the pestivirus of giraffe, were 0.28-0.43.  
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Suggestion for BVDV & BHV-1 control in Thailand 
This study provides evidence of a pronounced self-clearance process of both 
BVDV and BHV-1 infections. Based on experiences from Scandinavian countries 
and on the results in this study, this process can continue as long as introductions 
of the infections to non-infected herds are prevented. There seem to be no need to 
use vaccines for the control of the infections. The importance of biosecurity 
regarding e.g. animal introductions, insemination practices and treatments must be 
stressed. Repeated analysis of bulk tank milk has shown its effectiveness in many 
control programmes. Results from this low-cost test can indicate the status of the 
herds i.e. having an active infection (high antibody level) or a clearance of the 
virus (negative antibody status). The data must be provided to the farmers as a 
help when purchasing new animals i.e. only choose animals from BVDV-free and 
BHV-1-free herds. The traded animals should also have sufficient information i.e. 
origin of the animal, vaccination and breeding history. Based on the herd data, 
local authorities must be made aware of the transmission routes of the viruses from 
infected herds to the free-herds. All bull stations in the country that produce sperm 
should aim to be BVDV and BHV-1 free in the future. Other biological products 
made within the country for use in the animal populations should be shown to be 
free from virus contaminations. Imported animals into the country and biological 
products should also be shown to be free from both BVDV and BHV-1. Moreover 
it would be interesting to perform studies of the present pestivirus status in other 
animal populations e.g. beef cattle, swine and buffalo. 
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Concluding remarks 
Based on the studies presented in this thesis the following conclusions can be 
drawn:  
 
• The prevalence of BVDV and BHV-1 infections in north-eastern Thailand was 
significantly decreased, resulting from a self-clearance process. The self-clearance 
will most probably continue as long as there is awareness, among farmers, 
veterinarians and government authorities of herd biosecurity issues. There seem to 
be no reasons to use vaccines for the control of these infections in Thailand.   
 
• The available diagnostic techniques, comparative neutralisation tests, virus 
isolation, antibody and antigen ELISA tests and molecular techniques can be used 
as powerful tools for pestivirus investigations and in the control of such infections. 
 
• Further studies must be performed to elucidate the extent of reactivation of 
BHV-1 under different field conditions and how the atypical HoBi-like BVDV 
strain entered to the cattle population in Thailand.   
   31 
References 
Ackermann, M. & Engels, M. 2006. Pro and contra IBR-eradication. Veterinary 
Microbiology 113, 293-302.  
Ackermann, M., Muller, H.K., Bruckner, L. & Kihm, U. 1990. Eradication of infectious 
bovine rhinotracheitis in Switzerland: review and prospects. Veterinary Microbiology 23, 
365-70.  
Ackermann, M., Muller, H.K., Bruckner, L., Riggenbach, C. & Kihm, U. 1989. [The 
control of infectious bovine rhinotracheitis (IBR) in Switzerland from 1978 to 1988]. 
Schweizer Archiv fur Tierheilkunde 131, 397-407.  
Ackermann, M., Peterhans, E. & Wyler, R. 1982. DNA of bovine herpesvirus type 1 in the 
trigeminal ganglia of latently infected calves. American Journal of Veterinary Research 
43, 36-40.  
Ackermann, M. & Wyler, R. 1984. The DNA of an IPV strain of bovid herpesvirus 1 in 
sacral ganglia during latency after intravaginal infection. Veterinary Microbiology 9, 53-
63.  
Alenius, S., Larsson, B., Niskanen, R. & Jacobsson, S.-O. 1992. Bovine virus diarrhoea 
virus (BVDV) in cattle: Symptoms, diagnosis, prophylaxis and eradication Svensk 
Veterinärtidning. (In Swedish). 44, 51-62.  
Alenius, S., Lindberg, A. & Larsson, B. 1997. A national approach to the control of bovine 
viral diarrhoea virus. In 3rd ESVV symposium pestivirus infection, Edited by S. Edwards, 
D.J. Paton & G. Wensvoort. Lelystad, The Netherlands162-169. pp. 
Babiuk, L.A., van Drunen Littel-van den Hurk, S. & Tikoo, S.K. 1996. Immunology of 
bovine herpesvirus 1 infection. Veterinary Microbiology 53, 31-42.  
Baker, J.C. 1987. Bovine viral diarrhea virus: a review. Journal of the American Veterinary 
Medical Association 190, 1449-58.  
Baker, J.C. 1995. The clinical manifestations of bovine viral diarrhea infection. Veterinary 
Clinics of North America. Food Animal Practice 11, 425-45.  
Barkema, H.W., Bartels, C.J., van Wuijckhuise, L., Hesselink, J.W., Holzhauer, M., Weber, 
M.F., Franken, P., Kock, P.A., Bruschke, C.J. & Zimmer, G.M. 2001. [Outbreak of 
bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker 
vaccine contaminated with bovine virus diarrhea virus type 2.]. Tijdschrift Voor 
Diergeneeskunde 126, 158-65.  
Baroth, M., Orlich, M., Thiel, H.J. & Becher, P. 2000. Insertion of cellular NEDD8 coding 
sequences in a pestivirus. Virology 278, 456-66.  
Barros, S.C., Ramos, F., Pauperio, S., Thompson, G. & Fevereiro, M. 2006. Phylogenetic 
analysis of Portuguese bovine viral diarrhoea virus. Virus Research 118, 192-5.  
Baxi, M., McRae, D., Baxi, S., Greiser-Wilke, I., Vilcek, S., Amoako, K. & Deregt, D. 
2006. A one-step multiplex real-time RT-PCR for detection and typing of bovine viral 
diarrhea viruses. Veterinary Microbiology 116, 37-44.  
Beaudeau, F., Fourichon, C., Robert, A., Joly, A. & Seegers, H. 2004. Milk yield of cows 
and Bovine viral diarrhoea virus (BVDV) infections in 7,252 dairy herds in Bretagne 
(western France). In European Association for Animal Production. Bled, Slovenia 
Beaudeau, F., Fourichon, C., Robert, A., Joly, A. & Seegers, H. 2005. Bulk milk somatic 
cell counts and bovine viral diarrhoea virus (BVDV) infection in 7,252 dairy herds in 
Brittany (western France). Preventive Veterinary Medicine 72, 163-7.  
Becher, P., Avalos Ramirez, R., Orlich, M., Cedillo Rosales, S., König, M., Schweizer, M., 
Stalder, H., Schirrmeier, H. & Thiel, H.J. 2003. Genetic and antigenic characterization of 
novel pestivirus genotypes: implications for classification. Virology 311, 96-104.  
Becher, P., Orlich, M., Kosmidou, A., König, M., Baroth, M. & Thiel, H.J. 1999. Genetic 
diversity of pestiviruses: identification of novel groups and implications for 
classification. Virology 262, 64-71.  
Becher, P., Orlich, M., Shannon, A.D., Horner, G., König, M. & Thiel, H.J. 1997. 
Phylogenetic analysis of pestiviruses from domestic and wild ruminants. Journal of 
General Virology 78 ( Pt 6), 1357-66.    32
Becher, P., Orlich, M. & Thiel, H.J. 2001. RNA recombination between persisting 
pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal 
disease. Journal of Virology 75, 6256-64.  
Becher, P., Thiel, H.J., Collins, M., Brownlie, J. & Orlich, M. 2002. Cellular sequences in 
pestivirus genomes encoding gamma-aminobutyric acid (A) receptor-associated protein 
and Golgi-associated ATPase enhancer of 16 kilodaltons. Journal of Virology 76, 13069-
76.  
Beer, M., Wolf, G. & Kaaden, O.R. 2002. Phylogenetic analysis of the 5'-untranslated 
region of German BVDV type II isolates. J Vet Med B Infect Dis Vet Public Health 49, 
43-7.  
Belák, S. & Ballagi-Pordány, A. 1991. Bovine viral diarrhea virus infection: rapid diagnosis 
by the polymerase chain reaction. Archives of Virology. Supplementum 3, 181-90.  
Bendfeldt, S., Grummer, B. & Greiser-Wilke, I. 2003. No caspase activation but 
overexpression of Bcl-2 in bovine cells infected with noncytopathic bovine virus 
diarrhoea virus. Veterinary Microbiology 96, 313-26.  
Bielefeldt-Ohmann, H. 1995. The pathologies of bovine viral diarrhea virus infection. A 
window on the pathogenesis. Veterinary Clinics of North America. Food Animal Practice 
11, 447-76.  
Bitsch, V. 1973. Infectious bovine rhinotracheitis virus infection in bulls, with special 
reference to preputial infection. Applied Microbiology 26, 337-43.  
Bitsch, V., Hansen, K.E. & Ronshølt, L. 2000. Experiences from the Danish programme for 
eradication of bovine virus diarrhoea (BVD) 1994-1998 with special reference to 
legislation and causes of infection. Veterinary Microbiology 77, 137-43.  
Bland, J.M. & Altman, D.G. 1986. Statistical methods for assessing agreement between two 
methods of clinical measurement. Lancet 1, 307-10.  
Bolin, S., Moennig, V., Kelso Gourley, N.E. & Ridpath, J. 1988. Monoclonal antibodies 
with neutralizing activity segregate isolates of bovine viral diarrhea virus into groups. 
Brief report. Archives of Virology 99, 117-23.  
Bolin, S.R. 1990. Control of bovine virus diarrhoea virus. Revue Scientifique et Technique 
9, 163-71.  
Bolin, S.R. 1995a. Control of bovine viral diarrhea infection by use of vaccination. 
Veterinary Clinics of North America. Food Animal Practice 11, 615-25.  
Bolin, S.R. 1995b. The pathogenesis of mucosal disease. Veterinary Clinics of North 
America. Food Animal Practice 11, 489-500.  
Bolin, S.R. & Grooms, D.L. 2004. Origination and consequences of bovine viral diarrhea 
virus diversity. Veterinary Clinics of North America. Food Animal Practice 20, 51-68.  
Brock, K.V. & Chase, C.C. 2000. Development of a fetal challenge method for the 
evaluation of bovine viral diarrhea virus vaccines. Veterinary Microbiology 77, 209-14.  
Brodersen, B.W. 2004. Immunohistochemistry used as a screening method for persistent 
bovine viral diarrhea virus infection. Veterinary Clinics of North America. Food Animal 
Practice 20, 85-93.  
Brownlie, J. 1990. Pathogenesis of mucosal disease and molecular aspects of bovine virus 
diarrhoea virus. Veterinary Microbiology 23, 371-82.  
Brownlie, J., Clarke, M.C. & Howard, C.J. 1984. Experimental production of fatal mucosal 
disease in cattle. Veterinary Record 114, 535-6.  
Brownlie, J., Clarke, M.C., Howard, C.J. & Pocock, D.H. 1987. Pathogenesis and 
epidemiology of bovine virus diarrhoea virus infection of cattle. Annales de Recherches 
Veterinaires 18, 157-66.  
Brownlie, J., Hooper, L.B., Thompson, I. & Collins, M.E. 1998. Maternal recognition of 
foetal infection with bovine virus diarrhoea virus (BVDV)--the bovine pestivirus. 
Clinical and Diagnostic Virology 10, 141-50.  
Brownlie, J., Thompson, I. & Curwen, A. 2000. Bovine virus diarrhoea virus - strategic 
decisions for diagnosis and control. In Practice, 176-187.  
Bruschke, C.J., Weerdmeester, K., Van Oirschot, J.T. & Van Rijn, P.A. 1998. Distribution 
of bovine virus diarrhoea virus in tissues and white blood cells of cattle during acute 
infection. Veterinary Microbiology 64, 23-32.    33 
Bureau of Biotechnology in Livestock Production, DLD. 2005. Regulations for certification 
of artificial insemination center (in Thai). DLD, Bangkok. http://www.dld.go.th/biotech/ 
Source%20Docs/Requlation/Regulation.html.(accessed 23-Aug-06) 
Bureau of Disease Control and Veterinary Services, DLD. 2006. Farm free of Brucellosis, 
Paratuberculosis and Tuberculosis (in Thai). DLD, Bangkok. http://www.dld.go.th/ 
dcontrol/. (accessed 23-Aug-06).  
Carman, S., van Dreumel, T., Ridpath, J., Hazlett, M., Alves, D., Dubovi, E., Tremblay, R., 
Bolin, S., Godkin, A. & Anderson, N. 1998. Severe acute bovine viral diarrhea in 
Ontario, 1993-1995. Journal of Veterinary Diagnostic Investigation 10, 27-35.  
Charleston, B., Fray, M.D., Baigent, S., Carr, B.V. & Morrison, W.I. 2001. Establishment 
of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is 
associated with a failure to induce type I interferon. Journal of General Virology 82, 
1893-7.  
Chase, C.C., Elmowalid, G. & Yousif, A.A. 2004. The immune response to bovine viral 
diarrhea virus: a constantly changing picture. Veterinary Clinics of North America. Food 
Animal Practice 20, 95-114.  
Colett, M.S., Larson, R., Gold, C., Strick, D., Anderson, D.K. & Purchio, A.F. 1988. 
Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhea virus. 
Virology 165, 191-9.  
Collen, T., Douglas, A.J., Paton, D.J., Zhang, G. & Morrison, W.I. 2000. Single amino acid 
differences are sufficient for CD4(+) T-cell recognition of a heterologous virus by cattle 
persistently infected with bovine viral diarrhea virus. Virology 276, 70-82.  
Corapi, W.V., Donis, R.O. & Dubovi, E.J. 1990. Characterization of a panel of monoclonal 
antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea 
virus. American Journal of Veterinary Research 51, 1388-94.  
Couvreur, B., Letellier, C., Collard, A., Quenon, P., Dehan, P., Hamers, C., Pastoret, P.P. & 
Kerkhofs, P. 2002. Genetic and antigenic variability in bovine viral diarrhea virus 
(BVDV) isolates from Belgium. Virus Research 85, 17-28.  
Cranwell, M.P., Jones, J.R. & Wakeley, P.R. 2005. BVD virus type 2 in British cattle. 
Veterinary Record 156, 257-8.  
Da Silva, N., Zardoya, R., Santurde, G., Solana, A. & Castro, J.M. 1995. Rapid and 
sensitive detection of the bovine viral diarrhea virus genome in semen. Journal of 
Virological Methods 55, 209-18.  
de Verdier Klingenberg, K., Vagsholm, I. & Alenius, S. 1999. Incidence of diarrhea among 
calves after strict closure and eradication of bovine viral diarrhea virus infection in a 
dairy herd. Journal of the American Veterinary Medical Association 214, 1824-8.  
de Wit, J.J., Hage, J.J., Brinkhof, J. & Westenbrink, F. 1998. A comparative study of 
serological tests for use in the bovine herpesvirus 1 eradication programme in The 
Netherlands. Veterinary Microbiology 61, 153-63.  
Deng, R. & Brock, K.V. 1992. Molecular cloning and nucleotide sequence of a pestivirus 
genome, noncytopathic bovine viral diarrhea virus strain SD-1. Virology 191, 867-9.  
Deregt, D., Tessaro, S.V., Baxi, M.K., Berezowski, J., Ellis, J.A., Wu, J.T. & Gilbert, S.A. 
2005. Isolation of bovine viral diarrhoea viruses from bison. Veterinary Record 157, 448-
50.  
DLD 2004. Statistics of dairy cattle in Thailand, year 2004. In Statistics of Livestocks in 
Thailand, 2004 (in Thai). DLD, Bangkok. http://www.dld.go.th/ict/ yearly/yearly47/ 
early47.html (accessed 23-Aug-06).   
Donis, R.O. 1995. Molecular biology of bovine viral diarrhea virus and its interactions with 
the host. Veterinary Clinics of North America. Food Animal Practice 11, 393-423.  
Donis, R.O., Corapi, W.V. & Dubovi, E.J. 1991. Bovine viral diarrhea virus proteins and 
their antigenic analyses. Archives of Virology. Supplementum 3, 29-40.  
Duffell, S.J. & Harkness, J.W. 1985. Bovine virus diarrhoea-mucosal disease infection in 
cattle. Veterinary Record 117, 240-5.  
Edwards, S. 1990. The diagnosis of bovine virus diarrhoea-mucosal disease in cattle. Revue 
Scientifique et Technique 9, 115-30.  
Edwards, S., Chasey, D. & White, H. 1983. Experimental infectious bovine rhinotracheitis: 
comparison of four antigen detection methods. Research in Veterinary Science 34, 42-5.    34
Edwards, S., Newman, R.H. & White, H. 1991. The virulence of British isolates of bovid 
herpesvirus 1 in relationship to viral genotype. British Veterinary Journal 147, 216-31.  
Ellis, J.A., West, K.H., Cortese, V.S., Myers, S.L., Carman, S., Martin, K.M. & Haines, 
D.M. 1998. Lesions and distribution of viral antigen following an experimental infection 
of young seronegative calves with virulent bovine virus diarrhea virus-type II. Canadian 
Journal of Veterinary Research 62, 161-9.  
Elvander, M., Baule, C., Persson, M., Egyed, L., Ballagi-Pordány, A., Belák, S. & Alenius, 
S. 1998. An experimental study of a concurrent primary infection with bovine respiratory 
syncytial virus (BRSV) and bovine viral diarrhoea virus (BVDV) in calves. Acta 
Veterinaria Scandinavica 39, 251-64.  
Engels, M., Steck, F. & Wyler, R. 1981. Comparison of the genomes of infectious bovine 
rhinotracheitis and infectious pustular vulvovaginitis virus strains by restriction 
endonuclease analysis. Archives of Virology 67, 169-74.  
Falcone, E., Tollis, M. & Conti, G. 1999. Bovine viral diarrhea disease associated with a 
contaminated vaccine. Vaccine 18, 387-8.  
Fenton, A., Nettleton, P.F., Entrican, G., Herring, J.A., Malloy, C., Greig, A. & Low, J.C. 
1991. Identification of cattle infected with bovine virus diarrhoea virus using a 
monoclonal antibody capture ELISA. Archives of Virology. Supplementum 3, 169-74.  
Flores, E.F., Ridpath, J.F., Weiblen, R., Vogel, F.S. & Gil, L.H. 2002. Phylogenetic 
analysis of Brazilian bovine viral diarrhea virus type 2 (BVDV-2) isolates: evidence for a 
subgenotype within BVDV-2. Virus Research 87, 51-60.  
Fray, M.D., Paton, D.J. & Alenius, S. 2000. The effects of bovine viral diarrhoea virus on 
cattle reproduction in relation to disease control. Animal Reproduction Science 60-61, 
615-27.  
Fredriksen, B., Sandvik, T., Løken, T. & Ødegaard, S.A. 1999. Level and duration of serum 
antibodies in cattle infected experimentally and naturally with bovine virus diarrhoea 
virus. Veterinary Record 144, 111-4.  
Fritzemeier, J., Greiser-Wilke, I., Haas, L., Pituco, E., Moennig, V. & Liess, B. 1995. 
Experimentally induced "late-onset" mucosal disease--characterization of the 
cytopathogenic viruses isolated. Veterinary Microbiology 46, 285-94.  
Fritzemeier, J., Haas, L., Liebler, E., Moennig, V. & Greiser-Wilke, I. 1997. The 
development of early vs. late onset mucosal disease is a consequence of two different 
pathogenic mechanisms. Archives of Virology 142, 1335-50.  
Gibbs, E.P.J. & Rweyemamu, M.M. 1977. Bovine herpesvirus. Part I. The veterinary 
bulletin, 317-343.  
Givens, M.D., Heath, A.M., Brock, K.V., Brodersen, B.W., Carson, R.L. & Stringfellow, 
D.A. 2003. Detection of bovine viral diarrhea virus in semen obtained after inoculation of 
seronegative postpubertal bulls. American Journal of Veterinary Research 64, 428-34.  
Graham, D.A. 2001. Bovine viral diarrheoa virus (BVDV) on cattle farms - disease and 
control. Cattle practice 9, 111-118/.  
Graham, D.A., Clavert, V., Mooney, J., Crawford, J. & Clery, D. 2004. Birth of persistently 
infected calves in two herds using inactivated BVDV vaccines. In Second European 
Symposium on: BVDV control, Edited by P.S. Valle, C. Fourichon, A. Pereira & J.N. 
Ribeiro. Porto, Portugal: Paulo Costa. 87. pp. 
Graham, D.A., German, A., Mawhinney, K. & Goodall, E.A. 2003. Antibody responses of 
naive cattle to two inactivated bovine viral diarrhoea virus vaccines, measured by indirect 
and blocking ELISAS and virus neutralisation. Veterinary Record 152, 795-800.  
Graham, D.A., McShane, J., Mawhinney, K.A., McLaren, I.E., Adair, B.M. & Merza, M. 
1998. Evaluation of a single dilution ELISA system for detection of seroconversion to 
bovine viral diarrhea virus, bovine respiratory syncytial virus, parainfluenza-3 virus, and 
infectious bovine rhinotracheitis virus: comparison with testing by virus neutralization 
and hemagglutination inhibition. Journal of Veterinary Diagnostic Investigation 10, 43-8.  
Grom, J., Hostnik, P., Toplak, I. & Barlic-Maganja, D. 2006. Molecular detection of BHV-
1 in artificially inoculated semen and in the semen of a latently infected bull treated with 
dexamethasone. Veterinary Journal 171, 539-44.    35 
Grooms, D.L., Brock, K.V. & Ward, L.A. 1998. Detection of bovine viral diarrhea virus in 
the ovaries of cattle acutely infected with bovine viral diarrhea virus. Journal of 
Veterinary Diagnostic Investigation 10, 125-9.  
Gruber, A.D., Moennig, V., Hewicker-Trautwein, M. & Trautwein, G. 1994. Effect of 
formalin fixation and long-term storage on the detectability of bovine viral-diarrhoea-
virus (BVDV) RNA in archival brain tissue using polymerase chain reaction. Zentralbl 
Veterinarmed B 41, 654-61.  
Gunn, H.M. 1993. Role of fomites and flies in the transmission of bovine viral diarrhoea 
virus. Veterinary Record 132, 584-5.  
Hage, J.J., Schukken, Y.H., Schols, H., Maris-Veldhuis, M.A., Rijsewijk, F.A. & Klaassen, 
C.H. 2003. Transmission of bovine herpesvirus 1 within and between herds on an island 
with a BHV1 control programme. Epidemiology and Infection 130, 541-52.  
Hamers, C., Lecomte, C., Kulcsar, G., Lambot, M. & Pastoret, P.P. 1998. Persistently 
infected cattle stabilise bovine viral diarrhea virus leading to herd specific strains. 
Veterinary Microbiology 61, 177-82.  
Hofmann, M.A., Brechtbuhl, K. & Stauber, N. 1994. Rapid characterization of new 
pestivirus strains by direct sequencing of PCR-amplified cDNA from the 5' noncoding 
region. Archives of Virology 139, 217-29.  
Houe, H. 1999. Epidemiological features and economical importance of bovine virus 
diarrhoea virus (BVDV) infections. Veterinary Microbiology 64, 89-107.  
Houe, H. 2003. Economic impact of BVDV infection in dairies. Biologicals 31, 137-43.  
Houe, H. 2005. Risk assessment. In Bovine viral diarrhea virus: diagnosis, management 
and control. Edited by Goyal, S.M. and Ridpath, J. Blackwell Publishing Professional.  
Iowa. 35-63  pp. 
Houe, H., Baker, J.C., Maes, R.K., Ruegg, P.L. & Lloyd, J.W. 1995. Application of 
antibody titers against bovine viral diarrhea virus (BVDV) as a measure to detect herds 
with cattle persistently infected with BVDV. Journal of Veterinary Diagnostic 
Investigation 7, 327-32.  
Howard, C.J. 1990. Immunological responses to bovine virus diarrhoea virus infections. 
Revue Scientifique et Technique 9, 95-103.  
Howard, C.J., Clarke, M.C. & Brownlie, J. 1985. An enzyme-linked immunosorbent assay 
(ELISA) for the detection of antibodies to bovine viral diarrhoea virus (BVDV) in cattle 
sera. Veterinary Microbiology 10, 359-69.  
Hult, L. & Lindberg, A. 2005. Experiences from BVDV control in Sweden. Preventive 
Veterinary Medicine 72, 143-8; discussion 215-9.  
Jalali, A., Torstensson, M., Thrisner, D. & Nilsson, E. 2005. Applying the commercial 
indirect BVDV antibody ELISA to classify bulk milk samples according to the 
Scandinavian model. In 6th Pestivirus Symposium, Edited by E. Peterhans, M. Schweizer, 
M. Hofmann & J.-D. Tratschin. Thun, Switzerlands118. pp. 
Jones, L., van Campen, H., Xu, Z.C. & Schnackel, J.A. 2001. Comparison of neutralizing 
antibodies to type 1a, 1b and 2 bovine viral diarrhea virus from experimentally infected 
and vaccinated cattle. The Bovine Practitioner 35, 137-140.  
Juntti, N., Larsson, B. & Fossum, C. 1987. The use of monoclonal antibodies in enzyme 
linked immunosorbent assays for detection of antibodies to bovine viral diarrhoea virus. 
Zentralbl Veterinarmed B 34, 356-63.  
Kaashoek, M.J., Moerman, A., Madić, J., Rijsewijk, F.A., Quak, J., Gielkens, A.L. & van 
Oirschot, J.T. 1994. A conventionally attenuated glycoprotein E-negative strain of bovine 
herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12, 439-44.  
Kampa, J., Ståhl, K., Moreno-López, J., Chanlun, A., Aiumlamai, S. & Alenius, S. 2004. 
BVDV and BHV-1 infections in dairy herds in northern and northeastern Thailand. Acta 
Veterinaria Scandinavica 45, 181-92.  
Katz, J.B. & Hanson, S.K. 1987. Competitive and blocking enzyme-linked immunoassay 
for detection of fetal bovine serum antibodies to bovine viral diarrhea virus. Journal of 
Virological Methods 15, 167-75.  
Kendrick, J.W. & McEntress, K. 1987. The effect of artificial insemination with semen 
contaminated with IBR-IPV virus. Cornell Veterinarian 57, 3-11.    36
Kirkland, P.D., Richards, S.G., Rothwell, J.T. & Stanley, D.F. 1991. Replication of bovine 
viral diarrhoea virus in the bovine reproductive tract and excretion of virus in semen 
during acute and chronic infections. Veterinary Record 128, 587-90.  
Kofer, J., Wagner, P. & Deutz, A. 1999. BHV-1 infections in Styria (Austria) caused by 
intra-community trade. Deutsche Tierarztliche Wochenschrift 106, 231-3.  
Kramps, J.A., Perrin, B., Edwards, S. & van Oirschot, J.T. 1996. A European inter-
laboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 
infections. Veterinary Microbiology 53, 153-61.  
Kümmerer, B.M., Tautz, N., Becher, P., Thiel, H. & Meyers, G. 2000. The genetic basis for 
cytopathogenicity of pestiviruses. Veterinary Microbiology 77, 117-28.  
Lang-Ree, J.R., Vatn, T., Kommisrud, E. & Løken, T. 1994. Transmission of bovine viral 
diarrhoea virus by rectal examination. Veterinary Record 135, 412-3.  
Larsson, B., Alenius, S., Niskanen, R., Carlsson, U. & Jacobsson, S.-O. 1994. 
Establishment of cattle herds free from infections with bovine virus diarrhoea virus. In 
XVIII World Buiatrics Congress, Edited by G. Gentile. Bologna, Italy745-748. pp. 
Letellier, C. & Kerkhofs, P. 2003. Real-time PCR for simultaneous detection and 
genotyping of bovine viral diarrhea virus. Journal of Virological Methods 114, 21-7.  
Letellier, C., Kerkhofs, P., Wellemans, G. & Vanopdenbosch, E. 1999. Detection and 
genotyping of bovine diarrhea virus by reverse transcription-polymerase chain 
amplification of the 5' untranslated region. Veterinary Microbiology 64, 155-67.  
Liess, B. & Moennig, V. 1990. Ruminant pestivirus infection in pigs. Revue Scientifique et 
Technique 9, 151-61.  
Limbourg, B., Kerkhofs, P., Massard, C., Michelet, S., Saegerman, C. & Thiry, E. 2002. 
Avantages et inconvénients d’un plan de lutte contre la rhinotrachéite infectieuse bovine 
en Belgique. Ann. Méd. Vét. 147, 57-69.  
Lin, L.I. 1989. A concordance correlation coefficient to evaluate reproducibility. Biometrics 
45, 255-68.  
Lindberg, A. & Emanuelson, U. 1997. Effect of bovine viral diarrhea virus infection on 
average annual milk yield and average bulk milk somatic cell counts in Swedish dairy 
herds. Epid Sante Anim 31-32, 10.11.1-10.11.3.  
Lindberg, A., Groenendaal, H., Alenius, S. & Emanuelson, U. 2001. Validation of a test for 
dams carrying foetuses persistently infected with bovine viral-diarrhoea virus based on 
determination of antibody levels in late pregnancy. Preventive Veterinary Medicine 51, 
199-214.  
Lindberg, A., Niskanen, R., Gustafsson, H., Bengtsson, B., Baule, C., Belák, S. & Alenius, 
S. 2002. Prenatal diagnosis of persistent bovine viral diarrhoea virus (BVDV) infection 
by detection of viral RNA in fetal fluids. Veterinary Journal 164, 151-5.  
Lindberg, A., Stokstad, M., Løken, T., Alenius, S. & Niskanen, R. 2004. Indirect 
transmission of bovine viral diarrhoea virus at calving and during the postparturient 
period. Veterinary Record 154, 463-7.  
Lindberg, A.L. & Alenius, S. 1999. Principles for eradication of bovine viral diarrhoea 
virus (BVDV) infections in cattle populations. Veterinary Microbiology 64, 197-222.  
Loneragan, G.H., Thomson, D.U., Montgomery, D.L., Mason, G.L. & Larson, R.L. 2005. 
Prevalence, outcome, and health consequences associated with persistent infection with 
bovine viral diarrhea virus in feedlot cattle. Journal of the American Veterinary Medical 
Association 226, 595-601.  
Mars, M.H., Bruschke, C.J. & van Oirschot, J.T. 1999. Airborne transmission of BHV1, 
BRSV, and BVDV among cattle is possible under experimental conditions. Veterinary 
Microbiology 66, 197-207.  
Metzler, A.E., Matile, H., Gassmann, U., Engels, M. & Wyler, R. 1985. European isolates 
of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and 
reactivity with monoclonal antibodies. Archives of Virology 85, 57-69.  
Meyers, G. & Thiel, H.J. 1996. Molecular characterization of pestiviruses. Advances in 
Virus Research 47, 53-118.  
Meyling, A. 1984. Detection of BVD virus in viremic cattle by an indirect 
immunoperoxidase technique. In Recent advances in virus diagnosis. Haggue:Martinus 
Nijhoff Publishers. 37-46. pp.   37 
Mignon, B., Waxweiler, S., Thiry, E., Boulanger, D., Dubuisson, J. & Pastoret, P.P. 1992. 
Epidemiological evaluation of a monoclonal ELISA detecting bovine viral diarrhoea 
pestivirus antigens in field blood samples of persistently infected cattle. Journal of 
Virological Methods 40, 85-93.  
Miller, J.M., Whetstone, C.A. & Van der Maaten, M.J. 1991. Abortifacient property of 
bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction 
endonuclease analysis of viral DNA. American Journal of Veterinary Research 52, 458-
61.  
Moennig, V., Eicken, K., Flebbe, U., Frey, H.R., Grummer, B., Haas, L., Greiser-Wilke, I. 
& Liess, B. 2005. Implementation of two-step vaccination in the control of bovine viral 
diarrhoea (BVD). Preventive Veterinary Medicine 72, 109-14; discussion 215-9.  
Moennig, V., Houe, H. & Lindberg, A. 2005. BVD control in Europe: current status and 
perspectives. Anim Health Res Rev 6, 63-74.  
Moennig, V. & Liess, B. 1995. Pathogenesis of intrauterine infections with bovine viral 
diarrhea virus. Veterinary Clinics of North America. Food Animal Practice 11, 477-87.  
Moore, S., Gunn, M. & Walls, D. 2000. A rapid and sensitive PCR-based diagnostic assay 
to detect bovine herpesvirus 1 in routine diagnostic submissions. Veterinary 
Microbiology 75, 145-53.  
Murphy, F.A., Gibbs, E.P.J., Horzinek, M.C. & Studdert, M.J. 1999.  Herpesviridae. In 
Veterinary Virology, 3
rd edit. Academic Press. 301-305  pp. 
Nagai, M., Ito, T., Sugita, S., Genno, A., Takeuchi, K., Ozawa, T., Sakoda, Y., Nishimori, 
T., Takamura, K. & Akashi, H. 2001. Genomic and serological diversity of bovine viral 
diarrhea virus in Japan. Archives of Virology 146, 685-96.  
Nardelli, S., Marangon, S., Dalla Pozza, M., Ponzoni, A., Viel, L. & Brichese, M. 1999. 
Bovine herpesvirus 1 (BHV1) seroprevalence in the breeding cattle population of the 
Veneto region: prospects for the implementation of a control programme. Zentralbl 
Veterinarmed B 46, 735-40.  
Nettleton, P.F. & Entrican, G. 1995. Ruminant pestiviruses. British Veterinary Journal 151, 
615-42.  
Niskanen, R. 1993. Relationship between the levels of antibodies to bovine viral diarrhoea 
virus in bulk tank milk and the prevalence of cows exposed to the virus. Veterinary 
Record 133, 341-4.  
Niskanen, R., Alenius, S., Larsson, B. & Jacobsson, S.O. 1991. Determination of level of 
antibodies to bovine virus diarrhoea virus (BVDV) in bulk tank milk as a tool in the 
diagnosis and prophylaxis of BVDV infections in dairy herds. Archives of Virology. 
Supplementum 3, 245-51.  
Niskanen, R., Emanuelson, U., Sundberg, J., Larsson, B. & Alenius, S. 1995. Effects of 
Infection with Bovine Viral Diarrhoea Virus on health and reproductive performance in 
213 dairy herds in one county of Sweden. Preventive Veterinary Medicine 23, 229-237.  
Niskanen, R. & Lindberg, A. 2003. Transmission of bovine viral diarrhoea virus by 
unhygienic vaccination procedures, ambient air, and from contaminated pens. Veterinary 
Journal 165, 125-30.  
Niskanen, R., Lindberg, A., Larsson, B. & Alenius, S. 2000. Lack of virus transmission 
from bovine viral diarrhoea virus infected calves to susceptible peers. Acta Veterinaria 
Scandinavica 41, 93-9.  
Niskanen, R., Lindberg, A. & Tråvén, M. 2002. Failure to spread bovine virus diarrhoea 
virus infection from primarily infected calves despite concurrent infection with bovine 
coronavirus. Veterinary Journal 163, 251-9.  
Nylin, B., Madsen, K.G. & Ronshølt, L. 1998. Reintroduction of bovine herpes virus type 1 
into Danish cattle herds during the period 1991-1995: a review of the investigations in 
the infected herds. Acta Veterinaria Scandinavica 39, 401-13.  
OIE 2005. appendix 3.2.1.Bovine and small ruminant semen In Terrestrial Animal Health 
Code(2005). http://www.oie.int/eng/normes/mcode/ en_chapitre_3.2.1.htm.(accessed 23-
Aug-06).   
Paisley, L.G., Tharaldsen, J. & Jarp, J. 2001. A retrospective analysis of the infectious 
bovine rhinotracheitis (bovine herpes virus-1) surveillance program in Norway using 
Monte Carlo simulation models. Preventive Veterinary Medicine 50, 109-25.    38
Park, J.S., Moon, H.J., Lee, B.C., Hwang, W.S., Yoo, H.S., Kim, D.Y. & Park, B.K. 2004. 
Comparative analysis on the 5'-untranslated region of bovine viral diarrhea virus isolated 
in Korea. Research in Veterinary Science 76, 157-63.  
Paton, D.J., Carlsson, U., Lowings, J.P., Sands, J.J., Vilcek, S. & Alenius, S. 1995a. 
Identification of herd-specific bovine viral diarrhoea virus isolates from infected cattle 
and sheep. Veterinary Microbiology 43, 283-94.  
Paton, D.J., Christiansen, K.H., Alenius, S., Cranwell, M.P., Pritchard, G.C. & Drew, T.W. 
1998. Prevalence of antibodies to bovine virus diarrhoea virus and other viruses in bulk 
tank milk in England and Wales. Veterinary Record 142, 385-91.  
Paton, D.J., Ibata, G., Edwards, S. & Wensvoort, G. 1991. An ELISA detecting antibody to 
conserved pestivirus epitopes. Journal of Virological Methods 31, 315-24.  
Paton, D.J., Sands, J.J., Lowings, J.P., Smith, J.E., Ibata, G. & Edwards, S. 1995b. A 
proposed division of the pestivirus genus using monoclonal antibodies, supported by 
cross-neutralisation assays and genetic sequencing. Veterinary Research 26, 92-109.  
Pellerin, C., van den Hurk, J., Lecomte, J. & Tussen, P. 1994. Identification of a new group 
of bovine viral diarrhea virus strains associated with severe outbreaks and high 
mortalities. Virology 203, 260-8.  
Peterhans, E., Jungi, T.W. & Schweizer, M. 2003. BVDV and innate immunity. Biologicals 
31, 107-12.  
Pizarro-Lucero, J., Celedón, M.O., Aguilera, M. & de Calisto, A. 2006. Molecular 
characterization of pestiviruses isolated from bovines in Chile. Veterinary Microbiology 
115, 208-17.  
Potgieter, L.N. 1997. Bovine respiratory tract disease caused by bovine viral diarrhea virus. 
Veterinary Clinics of North America. Food Animal Practice 13, 471-81.  
Potgieter, L.N., McCracken, M.D., Hopkins, F.M. & Walker, R.D. 1984a. Effect of bovine 
viral diarrhea virus infection on the distribution of infectious bovine rhinotracheitis virus 
in calves. American Journal of Veterinary Research 45, 687-90.  
Potgieter, L.N., McCracken, M.D., Hopkins, F.M., Walker, R.D. & Guy, J.S. 1984b. 
Experimental production of bovine respiratory tract disease with bovine viral diarrhea 
virus. American Journal of Veterinary Research 45, 1582-5.  
Pritchard, G. 2001. Milk antibody testing in cattle. In Practice, 542-549.  
Pritchard, G.C. 1992. Epidemiology of BHV-1 infection in cattle breeding herds in Norfolk. 
In  Society for veterinary epidemiology and preventive medicine, Edited by M.V. 
Thrusfield. University of Edinburgh168-185. pp. 
Radostits, O.M., Gay, C.C., Blood, D.C. & Hinchcliff, K.W. 2000. Veterinary Medicine: A 
textbook of the Diseases of Cattle, Sheep, Pigs, Goats and Horses, 9
th.W.B. Saunders 
Company Ltd. 1173-1184 pp. 
Rebhun, W.C., French, T.W., Perdrizet, J.A., Dubovi, E.J., Dill, S.G. & Karcher, L.F. 1989. 
Thrombocytopenia associated with acute bovine virus diarrhea infection in cattle. 
Journal of Veterinary Internal Medicine 3, 42-6.  
Ridpath, J. 2005. Classification and Molecular Biology. In Bovine viral diarrhea virus: 
diagnosis, management and control. Blackwell Publishing.  Ames, Iowa, USA. 65-80 pp. 
Ridpath, J.F. 2003. BVDV genotypes and biotypes: practical implications for diagnosis and 
control. Biologicals 31, 127-31.  
Ridpath, J.F. & Bolin, S.R. 1995. Delayed onset postvaccinal mucosal disease as a result of 
genetic recombination between genotype 1 and genotype 2 BVDV. Virology 212, 259-62.  
Ridpath, J.F., Bolin, S.R. & Dubovi, E.J. 1994. Segregation of bovine viral diarrhea virus 
into genotypes. Virology 205, 66-74.  
Ridpath, J.F., Neill, J.D., Frey, M. & Landgraf, J.G. 2000. Phylogenetic, antigenic and 
clinical characterization of type 2 BVDV from North America. Veterinary Microbiology 
77, 145-55.  
Rikula, U., Nuotio, L., Aaltonen, T. & Ruoho, O. 2005. Bovine viral diarrhoea virus control 
in Finland 1998-2004. Preventive Veterinary Medicine 72, 139-42; discussion 215-9.  
Roeder, P.L. & Drew, T.W. 1984. Mucosal disease of cattle: a late sequel to fetal infection. 
Veterinary Record 114, 309-13.    39 
Rossmanith, W., Janacek, R. & Wilhelm, E. 2005. Control of BVDV-infection on common 
grassland--the key for successful BVDV-eradication in Lower Austria. Preventive 
Veterinary Medicine 72, 133-7; discussion 215-9.  
Saliki, J.T., Fulton, R.W., Hull, S.R. & Dubovi, E.J. 1997. Microtiter virus isolation and 
enzyme immunoassays for detection of bovine viral diarrhea virus in cattle serum. 
Journal of Clinical Microbiology 35, 803-7.  
Sandvik, T. 1999. Laboratory diagnostic investigations for bovine viral diarrhoea virus 
infections in cattle. Veterinary Microbiology 64, 123-34.  
Sandvik, T. 2005. Selection and use of laboratory diagnostic assays in BVD control 
programmes. Preventive Veterinary Medicine 72, 3-16. 
Sandvik, T., Fredriksen, B. & Løken, T. 1997. Level of viral antigen in blood leucocytes 
from cattle acutely infected with bovine viral diarrhoea virus. Zentralbl Veterinarmed B 
44, 583-90.  
Schirrmeier, H., Strebelow, G., Depner, K., Hoffmann, B. & Beer, M. 2004. Genetic and 
antigenic characterization of an atypical pestivirus isolate, a putative member of a novel 
pestivirus species. Journal of General Virology 85, 3647-52.  
Schlafer, D.H., Gillespie, J.H., Foote, R.H., Quick, S., Pennow, N.N., Dougherty, E.P., 
Schiff, E.I., Allen, S.E., Powers, P.A., Hall, C.E. & et al. 1990. Experimental 
transmission of bovine viral diseases by insemination with contaminated semen or during 
embryo transfer. Deutsche Tierärztliche Wochenschrift 97, 68-72.  
Schrijver, R.S. & Kramps, J.A. 1998. Critical factors affecting the diagnostic reliability of 
enzyme-linked immunosorbent assay formats. Revue Scientifique et Technique 17, 550-
61.  
Schweizer, M., Matzener, P., Pfaffen, G., Stalder, H. & Peterhans, E. 2006. "Self" and 
"Nonself" Manipulation of Interferon Defense during Persistent Infection: Bovine Viral 
Diarrhea Virus Resists Alpha/Beta Interferon without Blocking Antiviral Activity against 
Unrelated Viruses Replicating in Its Host Cells. Journal of Virology 80, 6926-35.  
Shannon, A.D., Mackintosh, S.G. & Kirkland, P.D. 1993. Identification of pestivirus carrier 
calves by an antigen-capture ELISA. Australian Veterinary Journal 70, 74-6.  
Shannon, A.D., Richards, S.G., Kirkland, P.D. & Moyle, A. 1991. An antigen-capture 
ELISA detects pestivirus antigens in blood and tissues of immunotolerant carrier cattle. 
Journal of Virological Methods 34, 1-12.  
Solis-Calderon, J.J., Segura-Correa, V.M. & Segura-Correa, J.C. 2005. Bovine viral 
diarrhoea virus in beef cattle herds of Yucatan, Mexico: Seroprevalence and risk factors. 
Preventive Veterinary Medicine 72, 253-262.  
Spagnuolo-Weaver, M., Allan, G.M., Kennedy, S., Foster, J.C. & Adair, B.M. 1997. 
Distribution of cytopathic and noncytopathic bovine viral diarrhea virus antigens in 
tissues of calves following acute experimental infection. Journal of Veterinary 
Diagnostic Investigation 9, 287-97.  
Stokstad, M., Niskanen, R., Lindberg, A., Thorén, P., Belák, S., Alenius, S. & Løken, T. 
2003. Experimental infection of cows with bovine viral diarrhoea virus in early 
pregnancy - findings in serum and foetal fluids. Journal of Veterinary Medicine Series B 
50, 424-9.  
Straub, O.C. 2001. Advances in BHV1 (IBR) research. Deutsche Tierarztliche 
Wochenschrift 108, 419-22.  
Stringfellow, D.A., Riddell, K.P., Givens, M.D., Galik, P.K., Sullivan, E., Dykstra, C.C., 
Robl, J. & Kasinathan, P. 2005. Bovine viral diarrhea virus (BVDV) in cell lines used for 
somatic cell cloning. Theriogenology 63, 1004-13.  
Tajima, M., Frey, H.R., Yamato, O., Maede, Y., Moennig, V., Scholz, H. & Greiser-Wilke, 
I. 2001. Prevalence of genotypes 1 and 2 of bovine viral diarrhea virus in Lower Saxony, 
Germany. Virus Research 76, 31-42.  
Tanyi, J. & Varga, J. 1992. Guidelines for the eradication of infectious bovine 
rhinotracheitis in Hungary. Acta Veterinaria Hungarica 40, 165-9.  
Tarry, D.W., Bernal, L. & Edwards, S. 1991. Transmission of bovine virus diarrhoea virus 
by blood feeding flies. Veterinary Record 128, 82-4.    40
Thiry, E., Saliki, J., Bublot, M. & Pastoret, P.P. 1987. Reactivation of infectious bovine 
rhinotracheitis virus by transport. Comparative Immunology, Microbiology and Infectious 
Diseases 10, 59-63.  
Thür, B., Zlinszky, K. & Ehrensperger, F. 1996. Immunohistochemical detection of bovine 
viral diarrhea virus in skin biopsies: a reliable and fast diagnostic tool. Zentralbl 
Veterinarmed B 43, 163-6.  
Tijssen, P., Pellerin, C., Lecomte, J. & van den Hurk, J. 1996. Immunodominant E2 (gp53) 
sequences of highly virulent bovine viral diarrhea group II viruses indicate a close 
resemblance to a subgroup of border disease viruses. Virology 217, 356-61.  
Trapp, S., Konig, P. & Beer, M. 2003. [Conventional and marked BHV-1 vaccines in 
Germany: a brief review]. Berliner und Munchener Tierarztliche Wochenschrift  116, 
208-15.  
Tråvén, M., Alenius, S., Fossum, C. & Larsson, B. 1991. Primary bovine viral diarrhoea 
virus infection in calves following direct contact with a persistently viraemic calf. 
Zentralbl Veterinärmed B 38, 453-62.  
Valle, P.S., Skjerve, E., Martin, S.W., Larssen, R.B., Osteras, O. & Nyberg, O. 2005. Ten 
years of bovine virus diarrhoea virus (BVDV) control in Norway: a cost-benefit analysis. 
Preventive Veterinary Medicine 72, 189-207; discussion 215-9.  
van Engelenburg, F.A., Maes, R.K., van Oirschot, J.T. & Rijsewijk, F.A. 1993. 
Development of a rapid and sensitive polymerase chain reaction assay for detection of 
bovine herpesvirus type 1 in bovine semen. Journal of Clinical Microbiology 31, 3129-
35.  
van Engelenburg, F.A., van Schie, F.W., Rijsewijk, F.A. & van Oirschot, J.T. 1995. 
Excretion of bovine herpesvirus 1 in semen is detected much longer by PCR than by 
virus isolation. Journal of Clinical Microbiology 33, 308-12.  
van Nieuwstadt, A.P. & Verhoeff, J. 1983. Epidemiology of BHV 1 virus infections in 
dairy herds. Journal of Hygiene 91, 309-18.  
van Oirschot, J.T. 1995. Bovine herpesvirus 1 in semen of bulls and the risk of 
transmission: a brief review. Veterinary Quarterly 17, 29-33.  
van Oirschot, J.T., Bruschke, C.J. & van Rijn, P.A. 1999. Vaccination of cattle against 
bovine viral diarrhoea. Veterinary Microbiology 64, 169-83.  
van Oirschot, J.T., Kaashoek, M.J., Maris-Veldhuis, M.A., Weerdmeester, K. & Rijsewijk, 
F.A. 1997. An enzyme-linked immunosorbent assay to detect antibodies against 
glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and 
vaccinated cattle. Journal of Virological Methods 67, 23-34.  
van Oirschot, J.T., Straver, P.J., van Lieshout, J.A., Quak, J., Westenbrink, F. & van Exsel, 
A.C. 1993. A subclinical infection of bulls with bovine herpesvirus type 1 at an artificial 
insemination centre. Veterinary Record 132, 32-5.  
Varady, E., Tuboly, T. & Derbyshire, J.B. 1994. Restriction endonuclease analysis of a 
porcine isolate of bovine herpesvirus type 1. Canadian Journal of Veterinary Research 
58, 65-6.  
Vilcek, S., Alenius, S., Paton, D.J., Mittelholzer, C. & Belák, S. 1999. Genetic clustering of 
bovine viral diarrhoea viruses in cattle farms: genetic identification and analysis of 
viruses directly from cattle sera. Veterinary Journal 158, 33-8.  
Vilcek, S. & Nettleton, P.F. 2006. Pestiviruses in wild animals. Veterinary Microbiology  
Vilcek, S., Nettleton, P.F., Herring, J.A. & Herring, A.J. 1994. Rapid detection of bovine 
herpesvirus 1 (BHV 1) using the polymerase chain reaction. Veterinary Microbiology 42, 
53-64.  
Vilcek, S., Paton, D.J., Durkovic, B., Strojny, L., Ibata, G., Moussa, A., Loitsch, A., 
Rossmanith, W., Vega, S., Scicluna, M.T. & Pálfi, V. 2001. Bovine viral diarrhoea virus 
genotype 1 can be separated into at least eleven genetic groups. Archives of Virology 146, 
99-115.  
Virakul, P., Suadsong, S., Suwimonteerabutr, J. & Singlor, J. 1997. Prevalence of infectious 
bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD), parainfluenza-3 (PI-3) and 
bovine respiratory syncytial (BRS) viruses in Thai dairy  farms. Thai journal of 
veterinary medicine 27, 295-313.    41 
Voges, H., Horner, G.W., Rowe, S. & Wellenberg, G.J. 1998. Persistent bovine pestivirus 
infection localized in the testes of an immuno-competent, non-viraemic bull. Veterinary 
Microbiology 61, 165-75.  
Vonk Noordegraaf, A., Labrovic, A., Frankena, K., Pfeiffer, D.U. & Nielen, M. 2004. 
Simulated hazards of loosing infection-free status in a Dutch BHV1 model. Preventive 
Veterinary Medicine 62, 51-8.  
Vonk Noordegraaf, A., Nielen, M., Franken, P. & Dijkhuizen, A.A. 2002. Simulation 
modelling of BHV1-control programme at national level, with special attention to 
sensitivity analysis. Livestock Production Science 76, 153-170.  
Vonk Noordegraaf, A.V., Jalvingh, A.W., de Jong, M.C., Franken, P. & Dijkhuizen, A.A. 
2000. Evaluating control strategies for outbreaks in BHV1-free areas using stochastic and 
spatial simulation. Preventive Veterinary Medicine 44, 21-42.  
Waage, S. 2000. Influence of new infection with bovine virus diarrhoea virus on udder 
health in Norwegian dairy cows. Preventive Veterinary Medicine 43, 123-35.  
Wellenberg, G.J., Verstraten, E.R., Mars, M.H. & Van Oirschot, J.T. 1998. Detection of 
bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme-
linked immunosorbent assays. Journal of Clinical Microbiology 36, 409-13.  
Willoughby, K., Valdazo-Gonzalez, B., Maley, M., Gilray, J. & Nettleton, P.F. 2006. 
Development of a real time RT-PCR to detect and type ovine pestiviruses. Journal of 
Virological Methods 132, 187-94.  
Winkler, M.T., Doster, A. & Jones, C. 2000. Persistence and reactivation of bovine 
herpesvirus 1 in the tonsils of latently infected calves. Journal of Virology 74, 5337-46.  
Wolfmeyer, A., Wolf, G., Beer, M., Strube, W., Hehnen, H.R., Schmeer, N. & Kaaden, 
O.R. 1997. Genomic (5'UTR) and serological differences among German BVDV field 
isolates. Archives of Virology 142, 2049-57.  
Xia, J.Q., Yason, C.V. & Kibenge, F.S. 1995. Comparison of dot blot hybridization, 
polymerase chain reaction, and virus isolation for detection of bovine herpesvirus-1 
(BHV-1) in artificially infected bovine semen. Canadian Journal of Veterinary Research 
59, 102-9.  
Zimmer, G.M., Van Maanen, C., De Goey, I., Brinkhof, J. & Wentink, G.H. 2004. The 
effect of maternal antibodies on the detection of bovine virus diarrhoea virus in 
peripheral blood samples. Veterinary Microbiology 100, 145-9.  
   42
Acknowledgements 
This study was performed at the Division of Ruminant Medicine and Veterinary 
Epidemiology, Department of Clinical Sciences of the Swedish University of 
Agricultural Sciences (SLU) in collaboration with the Joint Research and 
Development Division in Virology of SLU and of The National Veterinary 
Institute, Uppsala, Sweden. I express my gratitude to the Royal Thai Government 
for providing the grant to support my study.  
 
I wish to express my deepest gratitude to: 
 
Professor  Stefan Alenius, my supervisor, for giving me the opportunity and 
resources to perform my work, for a lot of encouragement, interesting discussions 
constructive criticism and friendship.  
 
Professor Camilla Björkman, for her kind help and also supportive discussions. 
 
Professor Ulf Emanuelson, for the wonderful management.  
 
Suneerat Aiumlamai, my co-supervisor  for her vision on the study, nice 
organization and advice.  
 
Professor  Jorge Moreno-López and Professor Sándor Belák for friendship and 
valuable guidance.  
 
Claudia Baule, for her terrific teaching and providing facilities for PCR work. 
You will always be my ‘hint’ in PCR.  
 
Rauni Niskanen, head of Department of Clinical Sciences for her kindness and 
friendship.  
 
Professor Tommy Linné, head of former Department of Veterinary Microbiology, 
for his friendship during the course of MSc study.  
 
Karin Östensson, for giving me the opportunity of the MSc study.  
 
Karl Ståhl, my co-author & friend, for all the nice collaborative work together.  
 
Ann Lindberg for providing me with the BVDV data and friendship.  
 
Maj Hjort,  Maud Söderberg,  Irene Dergel, Gunilla Åhlen, Alia Yacoub, Liu 
Lihong, and all helpful persons at SVA for fruitful advice and skilful laboratory 
work. 
  
Aran & Suthida Chanlund, my co-workers for skilful field/laboratory work and 
providing many materials.  
   43 
All lovely people at the Division of Ruminant Medicine and Veterinary 
Epidemiology, for all the friendships during my stay here. Big THANKS to Ann 
Nyman for all the supportive talks.  
 
All nice people at the Division of Clinical Radiology (SLU), for lovely parties and 
friendship.  
  
Prachak Puapermpoonsiri, Dean of the Faculty of Veterinary Medicine, Khon 
Kaen University (KKU), Thailand, for his kind support to my family.  
 
Sumate Pratumsuwan, the head of Dairy Farming Promotion Organization (DPO) 
Dairy Factory, North-eastern region, Thailand and his colleagues, for kind help 
and nice collaboration. 
  
Rapiphan Uavechanichkul, for kindly providing information about cattle semen 
production in Thailand.  
 
Suvichai Rojanasthein and all staff of Bovine team at Chiang Mai University, for 
the superb BTM samples from Chiang Mai.   
 
All Thai farmers for devoting their time, understanding and giving us the chance 
to do this job. Your ‘happy’ cows beat the fear of BHV-1 reactivation. 
 
Varaporn Sukolapong, my great (but short) teacher, for her endless support and 
taking care of my work during the time in Sweden.  
 
Ubonwan & Per Claeson,  Slil  &  Tussanee Srichaiyo, my older brothers and 
sisters, for their support and being extremely kind to my family.  
 
All Thai students at SLU & UU, in the past and at present, for sharing the nice 
time in Sweden. And all friends both in Thailand and elsewhere in the world for 
lovely postcards, e-mails and chats. 
 
My parents, Weerachai & Somsri Pattanawong, for their endless love and support. 
How nice and lucky I was born to be your daughter! Wisit & Wiwat Pattanawong, 
my brothers, for their help in many things for our family.  
 
The Thanyakhan family and Kampa family for all support.  
 
Last but not least, Naruepon & Yada Kampa, for always supporting, 
understanding and sharing with love in all sorts of times of our family life. You 
are my happiness! 
 
 
 
 
 